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ABSTRACT 
How do embryos develop with such poise from a single zygote to multiple cells 
with different identities, and yet survive? At the four-cell stage of the C. elegans embryo, 
only the blastomere EMS adopts the endo-mesoderm identity. This fate requires SKN-1, 
the master regulator of endoderm and mesoderm differentiation. However, in the absence 
of the RNA binding protein POS-1, EMS fails to fulfill its fate despite the presence of 
SKN-1. pos-1(-) embryos die gutless. Conversely, the RNA binding protein MEX-5 
prevents ectoderm blastomeres from adopting the endo-mesoderm identity by repressing 
SKN-1. mex-5(-) embryos die with excess muscle at the expense of skin and neurons. 
Through forward and reverse genetics, I found that genes gld-3/Bicaudal C, 
cytoplasmic adenylase gld-2, cye-1/Cyclin E, glp-1/Notch and the novel gene neg-1 are 
suppressors that restore gut development despite the absence of pos-1. Both POS-1 and 
MEX-5 bind the 3’UTR of neg-1 mRNA and its poly(A) tail requires GLD-3/2 for 
elongation. Moreover, neg-1 requires MEX-5 for its expression in anterior ectoderm 
blastomeres and is repressed in EMS by POS-1. Most neg-1(-) embryos die with defects 
in anterior ectoderm development where the mesoderm transcription factor pha-4 
becomes ectopically expressed. This lethality is reduced by the concomitant loss of med-
1, a key mesoderm-promoting transcription factor. 
Thus the endo-mesoderm identity of EMS is determined by the presence of SKN-
1 and the POS-1 repression of neg-1, whose expression is promoted by MEX-5. Together 
they promote the anterior ectoderm identity by repressing mesoderm differentiation. Such 
checks and balances ensure the vital plurality of cellular identity without the lethal 
tyranny of a single fate. 
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 Chapter I  
Introduction to C. elegans  
early embryogenesis 
  
2The question of blastomere identity determination 
In the perennial quest to discover the logic of life the nematode has been a tool 
and the embryo an ancient tomb. The nematode embryo provides the matter needed to 
approach a central question of biology; how a single cell becomes an adult. Early 
inquiries into “nemic embryogenesis” noted the regularity of nematode embryo 
development (Chitwood and Chitwood, 1937). However, it was the contribution of 
Theodor Boveri in the late 19th century and the publication of the embryogenesis of 
Parascaris equoram (Ascaris megalochephala) that laid the foundation of modern 
nematode embryology by establishing the fact that nematode embryogenesis is invariant 
and occurs through determinate cleavages (Ibid. p. 216). This means that cells are 
predestined, or programmed, to adopt an identity and then divide and branch into a 
lineage that forms particular organs or body parts.  
The motif that Boveri identified in early nematode embryogenesis is the 
asymmetric cleavage of a parental germinal cell (P) into an anterior somatic stem cell (S) 
and posterior parental germinal cell (P). The somatic stem cells generated by this motif 
produce the blastomeres required for the developing body. S1 cleaves into blastomeres A 
and B, which form the greater part of the ectoderm and contribute to the formation of the 
epithelium, pharynx, nervous system and excretory system. S2 cleaves into blastomeres 
E, which is the sole source of endoderm, and MSt, which in turn divides into blastomeres 
M for mesoderm and St for stomodeum in the nematodes that have one. S3 is the 
blastomere responsible for ectodermal epithelium of the posterior part of the body, 
whereas S4 is a blastomere that provides the embryo with the rectum and rectal glands as 
well as some muscular tissue. In some nematodes, P4 divides asymmetrically one more 
3time to generate the final somatic stem cell S5 that forms the epithelium of the gonoducts, 
and P5. However, in most nematodes P4 gives rise to the germ cells designated with 
perpetuating the motif in the following generation by maturing into a gamete, sperm or 
oocyte, which upon fertilization is anointed P0 (Ibid. pp. 216-217).  
Such an invariable course of development raises the question of how blastomeres 
are assigned a particular “identity” at the beginning embryogenesis. The question in 
this form is a reiteration of the central question above, how does a single cell divide and 
differentiate to become an adult?  
C. elegans as a model to study blastomere fate determination 
In order to dissect the genetic requirements for development and behavior, 
Caenorhabditis elegans was elected by Sydney Brenner as a model organism (Brenner, 
1974, 2003). C. elegans early embryogenesis follows the main course outlined by Boveri 
in Parascaris equoram (Figure 1.1) (Schierenberg, 2006; Sulston et al., 1983). Few 
important exceptions are worth noting. Anatomically, C. elegans does not have a 
stomodeum, however the designation EMSt was retained as EMS despite the absence of 
the “S” warranting body part. Additionally, the A and B blastomeres are designated ABa 
and ABp respectively. The designations S1 through S4 are substituted with AB, EMS, C 
and D in that order. Deviations not withstanding, C. elegans remains faithful to the 
Boverian account of nematode embryogenesis according to P. equaroam, including 
which body parts are derived from which blastomeres.  
  
4C. elegans early embryogenesis, blastomeres and their fates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1  
5Figure 1.1. Blastomere identity and fate is determined in C. elegans. The following 
schematic will be used to represent the early embryo in C. elegans. Circles represent 
blastomeres and their sizes are reduced to reflect cell cleavage. Colors represent 
developmental fates.  
6Two approaches have been used to study the basis of blastomere identity 
specification in C. elegans.  The first approach involves separating blastomeres to 
determine if their identity is arrived at independently in isolation or is informed by a 
neighboring cell.  The second approach is the pursuit of mutants in which blastomeres 
adopt the wrong identity and identifying the mutated gene responsible for the 
monstrosity.  
Cell interactions are required for blastomere fate specification 
The C. elegans zygote is able to develop to completion without an 
accommodating uterus. However, the fates of AB and EMS do not proceed as expected 
when cultured in isolation or when particular neighboring cells are ablated (Priess and 
Thomson, 1987). This indicates that cell interactions are important for part of early 
embryogenesis. Following are the three main cell-cell induction events that pattern the 
early embryo.  
P2 to ABp signaling specifies a blastomere that generates hypodermis and neurons 
The AB blastomere is the stem cell for the primary ectoderm. The two daughter 
cells born after AB division have different developmental fates. The anterior sister ABa 
produces the anterior pharynx made of muscle, gland, structural cells and neurons (Figure 
1.2). On the other hand, the posterior sister ABp gives rise to hypodermal cells (skin) and 
neurons. This difference in developmental fate is contingent upon ABp receiving an 
inductive signal from its neighbor P2 (Priess, 2005; Priess and Thomson, 1987). When 
cultured in isolation, AB divides into two identical sisters that both unroll ABa lineages. 
The developmental consequence of this ABp to ABa transformation is the doubling of 
anterior pharynx at the expense of hypodermal cells and neurons. Mutations in a gene 
7encoding the Delta ligand of Notch signaling, apx-1, cause a similar Anterior Phayrnx in 
eXcess phenotype (Apx). Obstructing the function of glp-1/Notch during the 4-cell stage 
using temperature sensitive alleles interrupts the P2 to ABp signaling resulting in an Apx 
phenotype as well (Figure 1.2) (Mello et al., 1994; Mickey et al., 1996). Notch signaling 
is therefore required for P2 to ABp cell-cell induction.  
MS to AB great granddaughter signaling specifies anterior phayrnx 
The Notch signaling pathway is required for a second inductive event that takes 
place between the MS blastomere and two granddaughters of ABa, ABalp and ABara 
(Figure 1.3) (Hutter and Schnabel, 1994; Priess and Thomson, 1987). If this inductive 
signal is obstructed, either by culturing ABa in isolation or as a consequence of glp-1 loss 
of function, ABa produces neurons and hypodermis but no pharyngeal cells (Priess and 
Thomson, 1987; Shelton and Bowerman, 1996). The developmental consequence of 
losing this second Notch inductive signal is a posterior pharynx derived from MS but no 
anterior pharynx due to the misspecification of ABa. Such a partial pharynx is referred to 
as Glp since it is arrived at by temperature sensitive glp-1 alleles originally isolated due 
to their role in Germ Line Proliferation (Figure 1.3) (Austin and Kimble, 1987; Priess et 
al., 1987). 
P2 to EMS signaling specifies endoderm blastomere 
When cultured in isolation, EMS divides into two identical sister cells that adopt 
an MS fate; mesoderm and no endoderm (Figure 1.4). Endoderm differentiation 
originating from the E blastomere is restored if EMS is brought into contact with P2 
(Goldstein, 1992). Mutagenesis screens pursuing More Of Mesoderm (Mom) mutants 
reveal the role of mom-2/Wnt and src-1/Src signaling in P2 to EMS signaling (Bei et al., 
82002; Rocheleau et al., 1997; Rocheleau et al., 1999; Thorpe et al., 1997). Briefly, MOM-
2/Wnt from the P2 cell signals EMS through the MOM-5/Frizzled receptor. This 
signaling event acts redundantly with SRC-1 to orient the EMS division axis and to 
promote cortical-release and nuclear translocation of WRM-1/β-catenin into the posterior 
nucleus of the dividing EMS that will become the nucleus of the E blastomere (Nakamura 
et al., 2005). High WRM-1 levels in the E nucleus modulate POP-1 function to promote 
endoderm differentiation. POP-1 is an HMG-box containing protein belonging to the 
TCF/LEF family of transcription factors. Loss of pop-1 function results in both EMS 
daughters adopting an E fate (Lin et al., 1995).  
9P2 to ABp signaling and the Apx phenotype 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 
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Figure 1.2. P2 to ABp signaling is necessary for the later to differentiate into hypodermal 
and neuronal cells (ectoderm). In the absence of this signaling, ABp remains identical to 
its sister ABa and response to inductive signals activating its mesodermal differentiation 
into anterior pharynx.  
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MS to AB great-granddaughter (AB8) signaling and the Glp phenotype 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 
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Figure 1.3. MS signals several of the 8 AB great granddaughters. However, only the 
descendants of ABa are responsive and in turn differentiate to build the anterior pharynx. 
In the absence of the signaling no anterior pharynx develops (Glp phenotype).   
13
P2 to EMS signaling and the Mom phenotype 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 
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Figure 1.4. EMS divides asymmetrically into Endoderm (E) and Mesoderm (MS) 
blastomeres due to P2 signaling. In the absence of the Wnt/Src signaling input from P2, 
EMS divides into two mesoderm blastomeres (MS). This is the More Of Mesoderm 
phenotype Mom. 
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Polarity axis formation is required for blastomere fate specification 
The first cell cleavage is asymmetric, with a larger anterior blastomere (AB) 
differentiating into a somatic fate and a smaller posterior blastomere (P1) retaining 
germline potential (Sulston et al., 1983).  Thus the asymmetry is of size and identity. The 
asymmetry in identity is an outcome of selective segregation of differentiation 
determinants to the appropriate daughter cell. Key loci for such determinants are P-
granules, which segregate to the posterior blastomere and are maintained in subsequent P 
blastomeres (Strome, 2005). Mutations in a series of genes named par-1 through par-6 
disrupt the initial asymmetric division with subsequent disruption of cell size, division 
axis, or PARtitioning of developmental determinants (Gonczy and Rose, 2005; 
Kemphues et al., 1988). 
par-4 is of particular interest in the context of blastomere specification. Embryos 
produced by homozygous par-4 mothers fail to produce intestinal cells. This means that 
the E blastomere fails to specify its endoderm fate. Using a temperature sensitive allele 
suggests that the critical period during which par-4 is required for the E blastomere 
specification begins during oogenesis, about 90 minutes before fertilization, and ends 
before the four-cell stage. In this sense, par-4 helps set up the requirements for the 
endoderm generating blastomere well before it is even born (Morton et al., 1992).  
Master Transcription Factors are required for blastomere fate specification 
As reviewed above, mutagenesis screens illuminated the genetic basis for the 
necessary cell-cell signaling interactions that dictate the fates of ABalp, ABara, ABp and 
E. Moreover, it became clear that the initial asymmetrical division is necessary for 
subsequent blastomeres to adopt the correct fate. Additional studies further illuminated 
16
the processes that determinate blastomere fate both positively (induction of fate) and 
negatively (preventing alternative fates). An important characteristic of these mutants is 
that they do not appear to function within signaling pathways and do not disrupt cell 
polarity and division asymmetry.  
Skn 
SKiNhead mutants skn-1 and skn-2 (later to be named pos-1) are recessive 
maternal effect embryonic lethal (Bowerman et al., 1992; Tabara et al., 1999). 
Heterozygous worms develop and grow to fertile adults. Homozygous progeny also 
develop and grow to fertile adults. However, these homozygous worms fail to provide 
their progeny with maternal doses of skn-1 and skn-2 mRNA leading to embryonic 
lethality. Embryos of skn-1 -/- or skn-2 -/- worms fail to specify the EMS blastomere 
leading to an embryo without EMS driven endoderm and mesoderm (Figure 1.5). In the 
case of skn-1, EMS transforms and adopts the fate of the C blastomere (Bowerman et al., 
1992). The name SKiNhead refers to the excess C derived hypodermis observed in this 
mutant. The focus of this thesis is skn-2/ pos-1 and will be addressed in detail below. 
skn-1 encodes a protein that is asymmetrically distributed in the early embryo 
(Figure 1.5) (Bowerman et al., 1993). At the two-cell stage, SKN-1 is detected in both 
nuclei but accumulates to much higher levels in P1. The asymmetry is emphasized in the 
four cells stage where SKN-1 accumulates in EMS and P2 compared to ABa and ABp.  
Sequence analysis reveals that SKN-1 is an atypical bZIP transcription factor that 
lacks a leucine zipper dimerization segment and has an N-terminal arm related to those of 
homeodomain proteins. Further highlighting the hybrid nature of SKN-1, in vitro studies 
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demonstrated that SKN-1 recognizes a bZIP half-sites adjacent to 5'AT-rich sequence in 
the minor groove recognized by homeodomain proteins (Blackwell et al., 1994). 
pal-1 
pal-1 is a second transcription factor that functions as a fate determinant in early 
embryogenesis. Originally identified as a homeodomain transcription factor required for 
male tail development (Waring and Kenyon, 1991). pal-1 mRNA was later demonstrated 
to be asymmetrically distributed in the 4-cell stage embryo in a manner similar to skn-1 
transcripts (Figure 1.5) (Hunter and Kenyon, 1996). Loss of both maternal and zygotic 
pal-1 function in early embryos results in C blastomere misspecification into unfamiliar 
cells (Figure 1.5) (Hunter and Kenyon, 1996). Loss of zygotic pal-1 function alone 
results in non-viable L1 larvae with gross posterior defects (Edgar et al., 2001). 
How are SKN-1 and PAL-1 asymmetrically distributed and how are their 
activities manifest in EMS and C, respectively but barred from P2? Answers to these 
questions became evident upon the characterization of two other categories of blastomere 
specification mutants.  
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The transcription factors skn-1 and pal-1 specify blastomere fate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 
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Figure 1.5. In skn-1 mutants, EMS adopts the C fate and develops into hypodermal cells. 
In pal-1 mutants, the C fate fails to materialize.   
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RNA binding proteins are required for Blastomere Specification in C. elegans 
Pie 
Pharynx and Intestine Excess (Pie) mutant embryos arrest with a P2 to EMS 
transformation leading to double the portion of endo-mesoderm at the expense of C 
derived hypodermis and body wall muscle, D derived muscle and P4 derived germline 
(Figure 1.6) (Mello et al., 1992). The effect of pie-1 is recessive maternal effect 
embryonic lethal. PIE-1 protein is restricted to the P lineage of the early embryo. The P2 
to EMS transformation of pie-1 mutants is suppressed by skn-1 loss of function (Mello et 
al., 1992). This genetic interaction uncovered the repressive nature of PIE-1 function in 
the P lineage in order to maintain germline identity at the expense of somatic 
differentiation. Although SKN-1 protein is present in the P2 blastomere (Bowerman et 
al., 1993), it is unable to initiate endo-mesoderm differentiation in the presence of PIE-1. 
Inquiry into the function of PIE-1 revealed its ability to inhibit zygotic transcription by 
regulating the activity of RNA Polymerase II (Batchelder et al., 1999; Mello et al., 1996; 
Seydoux and Dunn, 1997; Seydoux et al., 1996; Zhang et al., 2003).  
PIE-1 belongs to a family of proteins with two tandem zinc fingers (TZFs) first 
discovered due to their early response to mammalian growth factor and insulin (DuBois 
et al., 1990; Gomperts et al., 1990; Lai et al., 1990). The hallmark of this family is the 
presence of two tandem zinc fingers of the C(X8)C(X5)C(X3)H format, where X is any 
amino acid (Mello et al., 1992). The discovery of PIE-1 and its requirement in 
embryogenesis came hand in hand with that of another TZF required for blastomere 
specification, mex-1. 
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Mex  
In wildtype embryos, MS primarily produces mesodermal cells that build the 
posterior pharynx and contribute to body wall muscle. In mex-1 loss of function embryos, 
the four AB granddaughters adopt the MS fate as well (Figure 1.6) (Mello et al., 1992; 
Schnabel et al., 1996). The consequence of this blastomere fate misspecification is the 
Muscle EXcess Mex phenotype. As is the case with pie-1, reducing skn-1 function 
suppresses the ectopic MS differentiation in mex-1 embryos (Mello et al., 1992; Schnabel 
et al., 1996).  
mex-5 and mex-6 encode TZFs. Like mex-1, mex-5 also bars SKN-1 activity in the 
AB lineage. mex-5(-) embryos arrest with terminal phenotype similar to that of mex-1 
with AB granddaughters transforming into MS blastomeres leading to multiple 
pharyngeal clusters and excess muscle (Figure 1.6). skn-1 reduction tames the 
monstrosity. On the other hand, loss of mex-6, which shares 75% identity with mex-5 has 
no consequences on embryonic development. Loss of both mex-5 and mex-6 functions, 
however, result in a severe loss of differentiation as germ cells, anterior muscles and 
intestine are all absent (Figure 1.6). This suggests that mex-6 does indeed contribute to 
blastomere fate specification along side with mex-5 (Schubert et al., 2000). 
Two transcription factors belong to this category of Mex mutants. mex-2 and mex-
4 were later renamed efl-1 and dpl-1, respectively (Page et al., 2001). Although both 
transcription factors are expressed and act in the maternal germline, their loss of function 
results in embryos exhibiting the Mex phenotype. This connection between activity in the 
maternal germline and effect in the subsequent embryos reflects how embryogenesis is a 
process that is prepared for well before fertilization. In the case of efl-1 and dpl-1, their 
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activity induces the transcription of maternal genes including mex-5. Sufficient levels of 
mex-5 transcripts are thus deposited in the embryo and function to bar posterior 
determinants such as skn-1 from the AB lineage (Page et al., 2001). 
Ectopic skn-1 expression in the AB lineage is one way to transform anterior 
blastomeres to posterior muscle producing stem cells. Misexpression of pal-1 is a second 
way. Loss of mex-3 function results in ectopic pal-1 expression in the AB lineage and a 
consequent transformation to C fate (Figure 1.6). This defect is reversible by the loss or 
reduction of pal-1 function (Draper et al., 1996; Hunter and Kenyon, 1996). MEX-3 is a 
KH domain containing RNA binding protein (Draper et al., 1996). 
 
pos-1 and gld-1 
pos-1 was formerly referred to as skn-2 due to its loss of muscle development in a 
manner reminiscent to skn-1 (Craig Mello personal communication). However, pos-1 
exhibits additional phenotypes that reflect an overall defect in the P lineage (Tabara et al., 
1999). In pos-1 embryos, the P1 blastomere divides into defective P2 and EMS daughter 
cells (Figure 1.6). P2 fails to signal ABp leading to an Apx phenotype in two out of three 
embryos. EMS divides to produce two daughters, of which E fails to produce endoderm 
and MS exhibits signs of mesoderm development but overall fails to display a proper MS 
lineage. The consequence of this mediocre MS specification is the occasional loss of the 
second Notch signaling to ABa granddaughters ABalp and ABara. In one out of three 
embryos, this induction is absent and the embryo develops with no pharyngeal tissue, for 
MS does not produce the posterior pharynx and does not signal the ABa lineage to 
produce the anterior part. On the other hand, in cases where MS does succeed in 
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signaling the ABa lineage an Apx embryo results. In addition to the defects mentioned, 
pos-1 embryos also lack germ cells due to a misspecification of the P4 blastomere. 
Overall, cells of the P lineage exhibit abnormal division rates and it seems that only C 
and D specify properly (Figure 1.6). However this has not been rigorously tested. 
gld-1 was originally isolated as a gene required for germline development 
(Francis et al., 1995a; Francis et al., 1995b; Jones et al., 1996). gld-1 homozygous worms 
are sterile since germ cells fail to enter and properly proceed through meiosis. 
Knockdown of gld-1 mRNA has the same effect. However, in the interim between 
injecting gld-1 dsRNA and the onset of sterility, three consecutive types of embryos are 
produced. The first escapes gld-1 RNAi entirely. The second hatches and grows to 
become sterile adults.  The third type arrests as embryos exhibiting the pos-1 phenotype 
(Figure 1.6) (Jones et al., 1996)(Craig Mello personal communication). 
POS-1 belongs to the TZF family as is the case with PIE-1, MEX-1, MEX-5 and 
MEX-6 (Tabara et al., 1999). GLD-1 on the other hand affiliates with KH domain 
proteins such as MEX-3 (Jones and Schedl, 1995).  
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TZF and KHD proteins required for blastomere specification 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 
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Figure 1.6. A number of Tandem Zinc Finger (TZF) and K-Homology Domain (KHD) 
proteins are required for blastomere specification. Mutations in the genes encoding these 
proteins or knockdown of their expression, lead to characteristic embryonic lethal 
phenotypes. 
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Table 1.1 Summary of embryonic phenotypes. 
Gene Phenotype  Reference Notes 
glp-1 ABp è ABa Mello et al 1994, 
Mickey et al. 1996 
Second defect 
includes loss of 
anterior pharyngeal 
induction by MS 
apx-1 ABp è ABa Mello et al 1994, 
Mickey et al. 1996. 
 
mom-2 E è MS Bei et al., 2002; 
Rocheleau et al., 
1997; Rocheleau et 
al., 1999; Thorpe et 
al., 1997 
 
pop-1 MS è E Lin et al., 1995  
pie-1 P2 èEMS Mello et al., 1992  
mex-1 AB è 2EMS Mello et al., 1992  
skn-1 EMS è C Bowerman et al., 
1992 
 
pal-1 C è X Hunter and Kenyon, 
1996 
 
mex-5 AB è 2EMS Schubert et al., 2000  
mex-6 None Schubert et al., 2000 Additional defects 
when combined 
with mex-5(-) 
mex-3 AB è8C Draper et al., 1996; 
Hunter and Kenyon, 
1996 
 
pos-1 ABp èABa, EMS èX, P4 èX Tabara et al., 1999  
gld-1 ABp èABa, EMS èX, P4 èX Jones et al., 1996, 
Craig Mello 
unpublished results 
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TZF and KH proteins that function in blastomere specification are 
asymmetrically expressed 
The embryonic determinants surveyed above are asymmetrically expressed in the 
early embryo. MEX-5 and MEX-6 are segregated to the anterior of the zygote and in the 
nascent AB daughter cell (Schubert et al., 2000). This localization is dependent on 
upstream PAR proteins that function to polarize the zygote after fertilization. MEX-5/6 
also exclude the germplasm TZFs PIE-1, POS-1 and MEX-1 from the anterior thus 
enriching them in the posterior half of the zygote and subsequent P blastomeres 
(DeRenzo et al., 2003; Schubert et al., 2000). This negative interaction between MEX-5/6 
on the one hand and PIE-1, POS-1, and MEX-1 on the other requires the protein ZIF-1, 
which interacts with the zinc fingers of the germplasm TZFs to mediate their destruction 
(Cuenca et al., 2003).  
MEX-3 is also asymmetrically expressed in the anterior, whereas GLD-1 is 
restricted to the P lineage and blastomeres EMS, C and D. No GLD-1 is detected in the 
AB lineage by immuno-staining (Jones et al., 1996). 
 
TZF and KH proteins that function in blastomere specification bind 3’UTRs 
and regulate expression 
Our knowledge of the function of TZF proteins begins with the discovery of the 
mammalian protein Tristetraprolin (TTP) and its ability to bind AU rich regions in 
3’UTRs (Brooks and Blackshear, 2013). Delineating the binding specifies of RNA 
binding proteins and RNA sequences involves two different approaches. The RNA-
centered approach is a reiterative process in which the equilibrium dissociated constant 
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(Kd) of the interaction between purified recombinant protein and RNA is measured. This 
measurement is repeated after permutating the RNA to determine the contribution of each 
nucleotide in each position to the binding.  A second protein-centered approach infers the 
binding site from aligning sequences of bound RNA captured with the protein of interest. 
A combination of both approaches derived a conservative consensus sequence for 
GLD-1, UACU(C/A)A and a relaxed consensus (U>A/C/G)A(C>A)U(C/A>U)A (Ryder 
et al., 2004). A more complicated quantitative code was inferred in which heptamers 
were categorized as ‘strong’, ‘medium’ and ‘weak’ GLD-1 binding motifs (Table 1.2) 
(Wright et al., 2011). 
MEX-5 was deduced to have a relaxed RNA-binding specificity requiring at least 
six uridines within a 9 to 13 nucleotide window (Pagano et al., 2007). Starting with a 12 
nucleotide fragment recognized by POS-1, the consensus sequence of this protein was 
deduced to be UA(U2-3)(A/G)(A/G/U)(N1-3)G, where ‘N’ is any nucleotide (Table 1.2) 
(Farley et al., 2008). The MEX-3 consensus sequence was derived from non-biased in 
vitro selection experiment (SELEX) followed by the identification of 12-nucleotide 
sequence sufficient for MEX-3 binding. This sequence was then mutated to deduce that 
the MEX-3 consensus sequence was (A/G/U)(G/U)AGU(U/A/C)UA. Further analysis 
using ‘spacing’ mutants revealed that MEX-3 binds to a bipartite recognition element, 
which can be spaced from each other by up to eight nucleotides. Thus, the consensus 
sequence of MEX-3 has been derived as (A/G/U)(G/U)AGN0–8U(U/A/C)UA (Table 1.2) 
(Pagano et al., 2009). 
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Table 1.2: Consensus sequences of RBPs 
Protein Consensus binding sequence Reference Notes 
GLD-1 Conservative: UACU(C/A)A 
Relaxed:(U>A/C/G)A(C>A)U(C/A>U)A 
Ryder et al., 2004 
Wright et al., 2011 
See Wright et al., for 
alternative approach 
MEX-3 (A/G/U)(G/U)AGN0–8U(U/A/C)UA Pagano et al., 2009 SELEX based 
MEX-5 ≥75% U in N9-13 Pagano et al., 2007 ARE based 
POS-1 UA(U2-3)(A/G)(A/G/U)(N1-3)G Farely et al., 2008 glp-1 3’UTR based 
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POS-1 as negative regulator of expression (repressor) 
The POS-1 recognition element is overrepresented in the 3’UTRs of early 
embryonic transcripts (Farley et al., 2008). Experimental evidence establishes that indeed 
POS-1 regulates the expression of a number of maternal transcripts in the embryo. 
Interestingly, POS-1 functions as both repressor and an activator, depending on the 
transcript in question.  
Repression of glp-1 
Embryonic expression of glp-1 is restricted to anterior blastomeres (Evans et al., 
1994). GLD-1 and POS-1 are required for the repression of glp-1 in posterior blastomeres 
via their interaction with the spatial control region (SCR) of the 3’UTR (Marin and 
Evans, 2003; Ogura et al., 2003). The SCR consists of two POS-1 binding elements 
flanking a GLD-1 binding site (Farley and Ryder, 2012).  
SPN-4 is required for glp-1 expression in anterior blastomeres (despite the fact 
that SPN-4 is localized to posterior blastomeres). SPN-4 binds to a subregion of the 
temporal control region (TCR) in the glp-1 3’UTR (Ogura et al., 2003). SPN-4 and POS-
1 physically interact suggesting that the switch from repression to expression may hinge 
upon the interaction of these proteins.  
Interestingly, POS-1 binding to its recognition elements displaces GLD-1 
interaction with the SCR. However, both repress glp-1 translation (Farley and Ryder, 
2012). A possible utility for this is that POS-1 repression substitutes GLD-1 repression in 
the early embryo. The difference between the two repressions is that POS-1 could be 
responsive to SPN-4 derepression (via physical interaction), but perhaps GLD-1 is not. In 
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this sense, glp-1 expression goes from “off” (GLD-1 repression) to “locked” (POS-1 
repression) to “unlocked” (SPN-4 derepression). 
An alternative mode of countering POS-1 repression could be through MEX-5 
and MEX-6, which are required for glp-1 expression in the anterior blastomeres 
(Schubert et al., 2000). glp-1 3’UTR includes  predicted MEX-5 binding regions some of 
which have been experimentally verified in the TCR (Pagano et al., 2007). It is possible 
that MEX-5/6 promote the expression of glp-1 in the anterior by countering the waning 
repressive grip of GLD-1 and POS-1. However, this remains to be demonstrated. 
Repression of zif-1 
zif-1 is another gene with an embryonic expression pattern reminiscent of glp-1 
(Oldenbroek et al., 2012). ZIF-1 is a SOCS-box protein that interacts with the E3 
ubiquitin ligase subunit elongin C and is required for CCCH finger protein degradation. 
In the early embryo, ZIF-1 is activated in somatic daughter cells where it binds to germ-
plasm TZFs (PIE-1, MEX-1 and POS-1) to mediate their destruction (DeRenzo et al., 
2003). This contributes to the proper segregation of these blastomere fate determinants. 
On the other hand, these targeted proteins repress the translation of zif-1 in the posterior 
(Oldenbroek et al., 2012). Such mutual negative regulation contributes to the robust and 
rapid asymmetry observed. 
Using a fragmenting approach the contribution of separate 3’UTR regions to zif-1 
expression was determined and the recognition of these regions by RBPs was tested 
(Oldenbroek et al., 2012). Removal of Region II lead to loss of zif-1 expression in the 
anterior and ectopic expression in the posterior, which is a pattern opposite to that of 
wildtype embryos. This is interpreted to mean that region II is required for both the 
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repression in the posterior and the expression in the anterior. POS-1 and MEX-5 bind to 
region II. Loss of pos-1 function results in ectopic posterior expression of zif-1 whereas 
loss of mex-5 results in loss of anterior expression. Epistatic interaction suggests that 
MEX-5 promotes expression by countering POS-1 repression (Oldenbroek et al., 2012). 
This is reminiscent of the mechanism probably regulating glp-1 anterior expression. 
POS-1 as positive regulator of expression (derepressor/activator) 
Derepression of mom-2 
mom-2 offers an opposite example to glp-1 and zif-1 since its expression is 
restricted to the posterior (Oldenbroek et al., 2013). Using the same fragmenting 
approach used to study the zif-1 3’UTR, POS-1 was found to bind to region 4. Loss of 
pos-1 function results in loss of mom-2 expression in posterior blastomeres (Oldenbroek 
et al., 2013). PIE-1 and MEX-1 are also required for mom-2 expression and bind to 
region 3. Importantly, SPN-4 is required for mom-2 repression and binds to region 3 as 
well. However, PIE-1 and MEX-1 effectively compete with SPN-4 binding of region 3 
proposing a mechanism for posterior expression. Although POS-1 cannot compete with 
SPN-4 binding, the loss of mom-2 expression upon pos-1 loss of function suggest that 
POS-1 derepresses mom-2 expression (Oldenbroek et al., 2013). 
Derepression of nos-2 
Embryonic nos-2 expression is repressed until the P3 blastomere is born. There, 
and then in P4, nos-2 is expressed and is required for germ line specification 
(Subramaniam and Seydoux, 1999). POS-1 binds the 3’UTR of nos-2 and counters the 
repressive effect of MEX-3 and SPN-4 (D'Agostino et al., 2006; Jadhav et al., 2008).  
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Introduction to Research Question 
The study of early embryogenesis in C. elegans has matured towards an 
investigation into the regulated expression of maternally provided mRNA to orchestrate 
the establishment of blastomere identity in the embryo. These blastomeres then activate 
appropriate genetic programs and unroll a series of cell divisions and differentiate into 
lineages that interweave and complement one another. The genes surveyed above encode 
RNA binding proteins that regulate the expression of maternal mRNAs, transcription 
factors that initiate genetic programs, or signaling molecules that allow blastomeres to 
confirm their identity vis-a-vis neighboring cells. 
At this stage in our study of the embryo using C. elegans we lack a mechanistic 
understanding of how expression is modulated by the binding of TZF or KH domain 
proteins to the mRNA 3’UTRs. Complicating the answer is the fact that the same RNA 
binding protein could potentially act as a repressor or derepressor (activator) of 
expression, depending on the transcript and the cellular milieu in which the interaction 
occurs. The regulation is context dependent. Further challenging the quest is the fact that 
factors like PIE-1 can act at both the levels of transcription and translation.  
As a contribution to this research tradition I have studied pos-1. Of the defects 
manifest in pos-1 embryos, the loss of gut is paramount. This reflects a loss of endo-
mesoderm differentiation in the absence of pos-1. Thus the question I set out to answer is 
the following: Which maternal mRNA transcripts are regulated by pos-1 in order to 
ensure proper endo-mesoderm development and how does pos-1 regulate these 
transcripts?  
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Chapter II 
Identifying suppressors 
of 
pos-1 
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PREFACE 
Tae-Ho Shin uncovered the gld-3 suppression of the pos-1 and gld-1 gutless 
phenotype. GLD-3 had been identified by Tae-Ho due to its interaction with PIE-1 via 
Yeast-2-Hybrid. He later isolated an allele of gld-3 (alp-1(ne157)) as a gene required for 
Asymmetric Localization of P-granules. However, this strain was lost. In the context of 
studying the role of GLD-3 in blastomere specification, the genetic interactions with pos-
1 and gld-1 were discovered.  
Sandra Vergara conducted a mutagenesis screen that isolated two temperature 
sensitive dominant maternal effect sterile hermaphrodites. Since this phenotype, sans 
temperature sensitivity, was reminiscent of gld-3/alp-1(ne157), I tested if the two mutants 
were pos-1 suppressors by feeding them pos-1(RNAi). One of the two mutants laid dead 
eggs with restored endoderm, evident by gut granules. Craig Mello predicted the 
mutation was in the glp-1 locus since a fraction of embryos died with Glp pharynxes. 
Takao Ishidate confirmed the presence of a lesion by sequencing the glp-1 coding 
region. 
Meetu Seth performed the antibody staining of Cyclin E as part of her rotation, 
and Darryl Conte brought my attention to the RPL15 homology with NEG-1.  
 
Portions of this work have been presented publically as: 
Elewa, A., Shirayama, M., Miliaras, N., Shin, T., & Mello, C. (2010). gld-3 
functions in blastomere specification. C. elegans: Development and Gene 
Expression, EMBL, Heidelberg, Germany. 
Elewa, A., Ishidate, T., Vergara, S., Shin, T., Shirayama, M., & Mello, C. (2012). 
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Germline expressed GLP-1 regulates embryonic endoderm specification. C. 
elegans: Development, Cell Biology and Gene Expression, University of 
Wisconsin – Madison, USA. 
Elewa, A., Shirayama, M., Vergara, S., Ishidate, T., & Mello, C. (2013). 
Suppressors of pos-1 identify a novel function for GLP-1 and new players, 
gld-3, cyclin E and spos-1, involved in endoderm specification. International 
Worm Meeting, University of California – Los Angeles, USA 
Background information on Cyclin E has appeared in: 
Ishidate T, Elewa A, Kim S, Mello CC, Shirayama M. Divide and differentiate: 
CDK/Cyclins and the art of development. Cell Cycle 2014; 13:0 - -1; 
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ABSTRACT 
Mutations in the TZF encoding gene pos-1 result in maternal-effect embryonic 
lethal phenotypes due to the misspecification of several embryonic cell fates, including 
the failure to specify endoderm. In order to address the mechanism underlying this loss of 
endoderm, we conducted RNAi and genetic screens for factors that restore endoderm 
specification in pos-1 mutants. RNAi screening identified gld-3 (Bicaudal C), gld-2 (a 
cytoplasmic polyadenylase), cye-1 (Cyclin E) and the novel gene F32D1.6 (which we 
have named neg-1 “Negative Effect on Gut”). Forward mutagenesis screens identified an 
allele of glp-1 (Notch). In each case, suppression resulted in restored endoderm and 
pharyngeal-mesoderm differentiation. 
POS-1 has been shown to repress the translation of the glp-1 mRNA in posterior 
sister cells at the 4-cell stage of embryogenesis. However, GLP-1, a transmembrane 
receptor related to Notch, is not required for endoderm specification, and its mis-
expression in early pos-1 embryos has not been linked to the loss of endoderm fate. 
Interestingly, the glp-1(ne4298ts) allele we have identified has a lesion that alters a 
conserved amino acid in the 4th swi6 motif resulting in a strong temperature sensitive 
glp-1 loss of function phenotype. Surprisingly, the temperature-sensitive period (tsp) for 
glp-1 suppression of pos-1 occurs prior to fertilization, indicating that glp-1(ne4298ts) 
alters a maternal function that influences endoderm specification several hours later 
during early embryogenesis. 
GLD-3 has been proposed to act as an RNA-binding cofactor that recruits GLD-2 
to stimulate the cytoplasmic polyadenylation of targets important for germline 
development. We therefore investigated if they regulate the expression of cye-1 or neg-1 
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to affect endoderm specification during embryogenesis. Whereas embryonic levels of 
cye-1 were not affected by in absence of gld-3, neg-1 expression was lost. We therefore 
proceeded to analyze the regulation of neg-1 and its effect on embryogenesis. 
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The pos-1 phenotype 
All progeny of pos-1 homozygous hermaphrodites (hereafter pos-1 embryos) die 
with a compound phenotype (Figure 1.6).  
Loss of Germ cells 
The C. elegans zygote divides asymmetrically into a somatic daughter and a 
daughter cell retaining germline identity called P1. The same asymmetric division occurs 
in P1, P2 and P3. In wildtype worms, P3 divides into a somatic daughter D and the germ 
blastomere P4. P4 divides into two germ cells Z3 and Z4 that give rise to the germline. In 
pos-1 embryos, P4 identity is lost and the two germ cells Z3 and Z4 are absent (Tabara et 
al., 1999).  
Excess or loss of anterior pharynx 
In the absence of maternally provided pos-1, P2 fails to signal ABp via the 
Notch/GLP-1 signaling pathway. In accordance with this defect, glp-1 and its ligand apx-
1 are misexpressed. In pos-1(-) 4-cell stage embryos, GLP-1 is detected in all cells as 
opposed to the anterior ABa and ABp alone. On the other hand, APX-1 is undetected 
(Ogura et al., 2003). Failure of P2 to ABp signaling renders the ABp granddaughter cells 
responsive to mesoderm-inducing signals from the MS blastomere leading to an excess of 
anterior pharynx (Mello et al., 1994; Mickey et al., 1996). This is the case in the majority 
of pos-1(-) embryos. However, in one out of three pos-1(-) embryos no anterior pharynx 
develops due to failure of MS induction (Tabara et al., 1999).  
EMS hypo-specification 
The MS failure to induce anterior pharyngeal development echoes a profound 
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prior defect in EMS specification (Figure 2.1). In pos-1 embryos, the daughters of EMS 
fail to differentiate as expected, with 99% of embryos completely defective in endoderm 
development despite presence of SKN-1 and the fulfillment of P2 to EMS signaling 
hallmarks (Tabara et al., 1999). While EMS fails to differentiate to mesoderm and/or 
endoderm, it does not adopt a C-like lineage and fate. Instead, the defect in EMS 
specification resembles one of hypo-specification rather than misspecfication to an 
alternative fate. What is the proximate cause for EMS hypo-specification? 
Whereas SKN-1 levels are normal in pos-1 mutant embryos, we found that the 
downstream target med-1 fails to maintain robust expression. med-1 transcription is 
dependent on SKN-1 and is sustained by its own autoregulation (Maduro et al., 2007). To 
address the possibility that weak med-1 expression is the beginning of EMS failure in 
pos-1 mutants, we examined the effect of upregulated med-1 expression using a 
multicopy med-1::gfp strain (med-1(+++)). 83% of embryos produced by pos-1(-); med-
1(+++) developed endoderm tissue reflecting restored EMS identity. 
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pos-1 is necessary for EMS specification and gut development 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1  
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Figure 2.1. Embryos of pos-1(-) worms die gutless. The EMS blastomere fails to divide 
into the MS and E blastomeres (red in wildtype and grey in pos-1). pos-1(-) embryos 
therefore do not have birefringent gut granules (pink triangle). Another defect in pos-1 
embryos is the failure of ABp differentiation (light blue circle in wildtype, blue in pos-1(-
)). This is due to impaired cell-cell interaction between P2 and ABp. The developmental 
consequence of this defect is an unenclosed embryo, which is difficult to discern under 
polarized light. 
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gld-1 phenocopies pos-1 
The involvement of several TZF and KH proteins in blastomere fate specification 
suggested that other members of these families might be involved as well. Prior to the 
onset of gld-1(RNAi) sterility, a number of embryos are produced, the terminal batch of 
which die. The terminal phenotype of these gld-1 embryos is identical to pos-1 (Craig 
Mello unpublished observations).  
gld-3 and gld-2 suppress pos-1 
In a systematic survey of genetic interactions between TZF and KH genes 
conducted by Tae-Ho Shin (see Preface), our lab found that concomitant loss of gld-3 
function using RNAi restored endoderm specification in the progeny of pos-1(-) worms 
(>95% Figure 2.2). gld-3 (RNAi) also restored gut development in gld-1(RNAi) embryos 
(Craig Mello personal communication).  gld-3 encodes a KH domain protein homologous 
to Bicaudal C and required for proper germline development (Eckmann et al., 2002). 
Since GLD-3 recruits the cytoplasmic poly-A polymerase GLD-2 to promote the 
polyadenylation and translation of target transcripts required for spermatogenesis 
(Eckmann et al., 2004; Wang et al., 2002), we tested if gld-2 also suppresses pos-1. We 
fed pos-1(zu148) homozygous worms gld-2 RNAi food and found that 46% of pos-1; 
gld-2(RNAi) dead embryos had developed endoderm. 
Pursuing the proximate cause for loss of EMS specification in pos-1 
The penetrant loss of EMS fate in pos-1 and gld-1 mutants and the dramatic 
restoration upon gld-3 suppression allude to an elegant regulation of EMS fate 
specification. However, the aforementioned genes encode RNA binding proteins with 
likely roles in translation regulation. Therefore, my analysis focused on identifying the 
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transcripts that are evidently crucial for EMS fate specification and that rely on pos-1 and 
gld-3 for their proper expression.  
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gld-3 loss of function restores gut specification in the pos-1(-) background
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2  
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Figure 2.2. Birefringent gut granules (pink triangle) are restored in pos-1; gld-3(RNAi) 
embryos. The origin of the developing gut is EMS as opposed to alterative blastomeres 
(data not shown). We represent the gld-3 suppression of pos-1 as pos-1 negatively 
regulating gld-3, which in turn negatively regulates EMS fate.  
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Limitations and caveats 
The limitations of my inquiry include: 
1) I assumed pos-1 and gld-3 were regulating the translation of the same gene, which 
was crucial for EMS fate determination. It is conceivable that they were acting on 
two or more independent genes that function in parallel to one another. It is also 
conceivable that they regulate a process other than translation.  
2) I assumed that pos-1 was acting as a repressor while gld-3 was a promoter of this 
single gene. The Drosophila homolog of GLD-3, Bicaudal C, has been found to 
function in both poly(A) tail adenylation and deadenylation, depending on the 
complex it engages with. Such a dual role for GLD-3 is conceivable. Moreover, 
although pos-1 is a repressor of glp-1 expression, it is required for the expression 
of apx-1. Therefore, considering pos-1 a repressor and gld-3 an activator is only 
one way to think of their roles in EMS specification.   
3) It follows that I assumed that the single gene in question was an antagonist of 
EMS fate and that it could therefore be uncovered in a pos-1 suppressor screen. 
RNAi screen of essential genes in pursuit of pos-1 suppressors.  
Despite these limitations I proceeded with an RNAi screen due to its feasibility. I 
chose to screen approximately 1000 genes that are essential for embryogenesis (Kamath 
and Ahringer, 2003). This constitutes ~5% of C. elegans coding genes but is biased 
towards those with a role in connection with embryonic development. RNAi knockdown 
of any of these genes alone would result in a percentage of dead embryos.  
The pos-1 suppressor screen was performed by placing 5 to 10 L2 – L4 pos-
1(zu148) unc-42(e270) worms on RNAi food and allowing them to reach adulthood and 
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lay eggs. Embryos were then scored for gut granules. Positive hits were then retested by 
scoring the embryos of 4 to 8 individual worms fed the RNAi food in order to assess 
overall gut development and obtain average pos-1 suppression and standard deviation.  
Results of pos-1 suppressor RNAi screen 
The top suppressors of pos-1 are summarized in Table 2.1. Notably, gld-2 was 
identified as a suppressor of pos-1, which confirmed our earlier finding that it can restore 
gut specification in the absence of pos-1.  
rev-1 encodes a translesion DNA polymerase capable of replicating DNA despite 
the presence of hindering lesions and is a target of the mesoderm determining 
transcription factor HLH-8/Twist (Holway et al., 2006; Wang et al., 2006b). cye-1/Cyclin 
E initiates the S-phase of the cell cycle and regulates the decision between cell 
proliferation and differentiation (Ishidate et al., 2014). lrr-1 encodes a leucine rich repeat-
containing protein and is required for regulating the extent of DNA replication during S 
phase (Merlet et al., 2010). rba-1 is a chromatin remodeling factor that has been 
implicated in DNA replication coupled chromatin assembly pertinent to neuronal bilateral 
asymmetry (Nakano et al., 2011). rpn-8 is a proteasome regulatory particle that functions 
in SKN-1 turnover after EMS division (Du et al., 2014). It is conceivable that rpn-8 
knockdown causes an accumulation of SKN-1 sufficient to activate gut differentiation. 
A gene that suppressed pos-1 in a reproducible and robust manner was the 
uncharacterized gene F32D1.6. The quality of suppression was on par with that of gld-3 
and it was predicted to be a target of pos-1 by virtue of a POS-1 consensus binding 
element in its 3’UTR. I pursued this gene for future study. 
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Table 2.1. Results of pos-1 suppressor RNAi screen 
Sequence 
Name 
Gene 
Name RNAi phenotype* 
pos-1 suppression 
(Gut+) Function 
F32D1.6  20% Emb, Lvl, Bmd 78.8% ±10.8 (n=7) unknown 
ZK675.2 rev-1 100% Emb 76.7% ±14.4 (n=4) Translesion DNA polymerase 
K07A1.11 rba-1 100% Emb, Pvl, Unc.Prz 46.7% ±29.2 (n=8) RBAp48 related 
R12E2.3 rpn-8 100% Emb, Ste (no ooc) 23.8% ±5.8 (n=4) Proteasome regulatory particle 
ZC308.1 gld-2 100% Emb, Ste (no ooc) 41.2% ±12.3 (n=4) Cytoplasmic poly(A) polyermase 
C37A2.4 cye-1 10% Emb, Clr 19.1% ±17.7 (n=5) Cyclin E 
F33G12.4 lrr-1 100% Emb 29.9% ±33.1 (n=6) Leucine-Rich Repeat protein 
Phenotypes from Ahringer Database. 
Emb = Embryonic lethal Pvl = Protruding vulva 
Clr = Clear   Ste = Sterile 
Lvl = Larval lethal  Bmd = Body morphology defects 
Unc = Uncoordinated Prz = Paralyzed 
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Cyclin E regulates cell cycle and differentiation 
Cyclins owe their name to their oscillating patterns of expression throughout the 
cell cycle. This cyclic property enables cyclins to provide an active kinase complex with 
substrate specificity appropriate for each of the cell cycle phases (Morgan, 1997). Cyclin 
E binds and functions with its dependent kinase CDK2 to mediate the entry of cells into 
the DNA synthesis (S) phase and the expression of S-phase specific genes (Moroy and 
Geisen, 2004). An increasing number of studies have connected Cyclin E with 
differentiation processes (Ishidate et al., 2014). Four examples are provided below from 
research on Drosophila melanogaster and C. elegans somatic and germline development.  
Cyclin E in Drosophila 
Individual neuroblasts produced from corresponding positions in thoracic and 
abdominal segments usually acquire similar fates in fruit fly. However, the neuroblast 
NB6-4 lineage is a case where variations exist (Akiyama-Oda et al., 1999). In the 
thoracic segments of the embryonic central nervous system (CNS), NB6-4t divides 
asymmetrically to generate one neuronal and one glial precursor cell. The neuronal 
precursor cell then divides several times in stem-cell mode to generate a neuronal sub 
lineage. The glial precursor cell, however, divides twice to generate three glia (Figure 
2.3). In the abdominal segment of the embryonic CNS, the corresponding neuroblast 
(NB6-4a) merely divides symmetrically into two glial cells (Figure 2.3). Mutations in 
homeotic genes abd-A and abd-B cause abdominal NB6-4 to transform into the more 
elaborate thoracic lineage. Conversely, overexpression of abd-A results in the opposite 
NB6-4t to NB6-4a transformation (Berger et al., 2005a, b). Genetic and biochemical 
evidence demonstrate that these homeotic transformations are dependent on Cyclin E. 
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Loss of function mutations in Cyclin E result in thoracic NB6-4 adopting the fate of its 
abdominal counterpart and generating only two glial cells. Conversely, ectopic 
expression of Cyclin E in abdominal NB6-4 transforms its mode of division to one that 
resembles thoracic NB6-4. In situ hybridization reveals that Cyclin E is expressed in 
thoracic NB6-4 but not in the abdominal counterpart (Figure 2.3). After the first 
asymmetric division, Cyclin E mRNA is detected in the neuronal precursor but not in the 
glial precursor daughter cell. In abd-A mutant embryos, which exhibit an abdominal to 
thoracic NB6-4 transformation, Cyclin E mRNA is detected in the transformed NB6-4a 
lineages. Importantly, overexpression of abd-A, which causes the opposite 
transformation, reduces Cyclin E mRNA levels in the thoracic segment. Perhaps most 
critical, the homeotic transformation observed in abd-A mutants is suppressed by 
mutations in Cyclin E. This epistatic relationship, along with potential Abd-A-binding 
sites in the Cyclin E promoter, suggest that homeotic genes in the Bithorax complex 
regulate the differential expression of Cyclin E, which maintains the neuroblast stem cell 
fate (Berger et al., 2005a).  
          An alternative mode by which Cyclin E regulates differentiation has been 
described in Drosophila female germline stem cells (Ables and Drummond-Barbosa, 
2013). Germline stem cells deficient in Cyclin E or its canonical partner cyclin-dependent 
kinase 2 (Cdk2) display normal rates of proliferation as long as they are within the stem 
cell niche, emphasizing that the cell cycle machinery is still intact. However, these Cdk-
2/Cyclin E deficient germ cells fail to maintain their proliferative fate due to a weakened 
response to niche bone morphogenetic protein (BMP) signals, which are required for 
germ stem cell maintenance. The outcome of this failure is that germ cells are lost from 
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the stem cell niche, arrest at G1 stage and undergo excessive growth without committing 
to a clear differentiated fate. This impaired response to BMP induction suggests that 
Cyclin E and Cdk2 maintain germline stem cells by modulating its response to niche 
derived signals (Ables and Drummond-Barbosa, 2013). 
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Cyclin E is elevated in Drosophila neuroblasts during asymmetric division of NB6-4t 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3  
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Figure 2.3. Asymmetric cell division of thoracic neuroblast 6-4 (NB6-4). NB6-4t divides 
asymmetrically to produce a neuroblast (blue) and gliablast (orange) whereas NB6-4a 
divides symmetrically giving rise to 2 glial cells. The neuroblast identity is maintained by 
high levels of Cyclin E (white stars), which is significantly reduced in NB6-4a. 
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Cyclin E in C. elegans 
The C. elegans germline consists of two gonad arms connected at the uterus 
(Kimble and Crittenden, 2005). The distal end of the each gonad arm (relative to the 
uterus) harbors a stem cell niche of proliferating germ cells known as the ‘mitotic zone’ 
(Figure 2.4). However, unlike other stem cell systems in which a small number of stem 
cells divide asymmetrically, the C. elegans mitotic zone harbors >200 syncytial cells that 
divide into equivalent daughters. The fates of these daughters are not determined by 
asymmetric division but by their position relative to the niche signal.  
The proliferative mode of the mitotic zone is promoted by Notch signaling from 
the Distal Tip Cell (DTC) (Crittenden et al., 2003; Kimble and Simpson, 1997). The DTC 
presents the LAG-2/Delta ligands, which activates GLP-1/Notch receptor cleavage in 
germ cells thereby unleashing the Notch intracellular domain (ICD). Once released from 
the plasma membrane, Notch ICD enters the germ-cell nucleus where it interacts with 
CSL family transcription factors to regulate the expression of genes necessary for the 
proliferative fate (Christensen et al., 1996).  
Beyond the range of Notch signaling, mitotic germ-cells enter the transition zone 
and enter meiosis, in part through the function of GLD-1. GLD-1 is a KH domain RNA 
binding protein that accumulates at low levels in the distal end of the germline but 
gradually rises until reaching the maximum level in the transition zone. In the absence of 
GLP-1/Notch signaling, GLD-1 is ectopically expressed in the distal region of the 
germline (Hansen et al., 2004). Conversely, overexpression of GLD-1 in the distal end 
abrogates the proliferative fate and causes the germ cells to enter meiosis prematurely. 
Consistent with these observations, GLD-1 binds the 3’UTR of glp-1 mRNA and 
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represses its translation in the embryo and meiotic region of the germline (Marin and 
Evans, 2003). Collectively, these genetic and biochemical interactions suggest a mutual 
repressive feedback between Notch backed proliferation and GLD-1 based 
differentiation.  
The proliferative fate has also been shown to depend on CDK-2/CYE-1, since 
premature meiotic differentiation is enhanced in a weak glp-1 mutant background upon 
cye-1 or cdk-2 RNAi (Fox et al., 2011). CDK-2/CYE-1 directly phosphorylates GLD-1 in 
vitro and cye-1 RNAi leads to an increase in GLD-1 levels in the distal end of the gonad. 
Since mutating the phosphorylation site in GLD-1 phenocopies this increase in distal 
GLD-1 levels it is likely that that CDK-2/CYE-1 could block the switch to meiotic 
differentiation by targeting GLD-1 and thereby maintain the proliferative mode of mitotic 
germ cells (Jeong et al., 2011). However, since reduction of cdk-2 or cye-1 function leads 
to premature meiotic entry even in the absence of gld-1, CDK-2/CYE-1 must also be 
promoting proliferation through a GLD-1 independent pathway.  
The role of Cyclin E in C. elegans vulval development may offer a clue to this 
additional mode of action. During vulva development in C. elegans, the Anchor Cell 
(AC) signals the vulval precursor cell (VPC) P6.p via the EGFR signaling pathway. Upon 
this induction, P6.p then signals its neighboring VPCs P5.p and P7.p via the Notch 
signaling pathway to adopt a different fate. By utilizing a NICD::GFP reporter, it was 
demonstrated that CYE-1 exerts a stabilizing effect on the intercellular pool of NICD in 
VPCs (Nusser-Stein et al., 2012). It is enticing to surmise that CYE-1 may exert a similar 
stabilizing effect on NICD molecules in the germline mitotic zone (Figure 2.4). If this 
indeed is the case, then Cyclin E would maintain the proliferative mode of mitotic germ 
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cells by both positively stabilizing the Notch proliferative cue and negatively targeting 
GLD-1 to prevent differentiation. Interestingly, GLD-1 binds to the 3’UTR of cye-1 and 
represses its translation beyond the proliferative zone, emphasizing the mutual negative 
feedbacks that govern proliferation versus differentiation decisions in the germline 
(Biedermann et al., 2009) (Figure 2.4). 
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Cyclin E maintains proliferative fate in C. elegans germline 
 
 
 
 
 
 
 
Figure 2.4  
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Figure 2.4. (A) Transition from mitosis into meiosis in C.elegans germline. The Distal 
Tip Cell (DTC in green) caps the distal end of the germline and induces mitotic 
proliferation (blue). Beyond the reach of the DTC Notch signaling, germ cells transition 
into the differentiation zone in a GLD-1 dependent manner, where they undergo meiosis 
(red). (B) Model for Cyclin E in maintenance of germ stem-cell fate in C. elegans. The 
boundary between the proliferative and transition zones is maintained by 2 mutual 
negative regulations: CDK-2/ CYE-1 and GLP-1 inhibit accumulation of GLD-1 in the 
mitotic proliferation zone, while GLD-1 represses the translation of cye-1 and glp-1 
transcripts in the transition zone. It remains to be seen if CYE-1 can maintain 
proliferation zone by enhancing GLP-1 ICD induction in the similar way it does in vulval 
development. 
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Embryonic Cyclin E levels are not affected by pos-1 or gld-3 loss of function 
Given the role of Cyclin E in maintaining the proliferative fate of germ cells, I 
hypothesized that gut development may be lost in pos-1(-) embryos due to an 
overexpression of Cyclin E preventing endo-mesoderm differentiation. This hypothesized 
overexpression would require gld-3. In this model, cye-1 is a gut antagonist due to its 
support of the germline proliferative fate, pos-1 is a repressor of cye-1 translation and 
gld-3 is an activator of cye-1 expression. This would explain why cye-1(RNAi) restores 
gut specification in the pos-1(-) background.  
In order to test this hypothesis we immunostained early embryos from wildtype, 
pos-1(zu148) and gld-3(RNAi) to detect Cyclin E CYE-1/Cyclin E levels were quantified 
and compared to co-stained histone. Contrary to our hypothesis, CYE-1 levels were not 
upregulated in the absence of pos-1 function. Moreover, despite a reduction in CYE-1 
levels in gld-3(RNAi) embryos, the reduction was less than that observed in the absence 
of pos-1 function (Figure 2.5). These two results made it improbable that pos-1(-) 
embryos are gutless due to a gld-3 dependent increase in CYE-1 levels. 
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CYE-1/Cyclin E is not elevated in pos-1 mutant embryos 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 
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Figure 2.5. The intensity of antibody signal recognizing CYE-1 was compared to that 
from an antibody recognizing histones. The average ratio of CYE-1 : Histone signal in 
wildtype embryos was 1.5. This ratio was reduced to less than 0.5 after cye-1(RNAi). The 
ratio did not increase after pos-1 RNAi. gld-3 RNAi reduced the CYE-1 : Histone signal 
to 1, suggesting that GLD-3 may be required for cye-1 expression. Immunostaining was 
performed by Meetu Seth. 
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glp-1ts is a suppressor of pos-1 
Concurrent with the RNAi suppressor screen, a mutagenesis screen in our lab 
identified a mutant, ne4298ts, as temperature sensitive haplo-insufficient. This means that 
heterozygous hermaphrodites are sterile at 25°C. Since gld-3 was initially identified as a 
haplo-insufficient maternal-effect sterile mutant, I tested to see if ne4298ts was also a 
pos-1 suppressor and indeed it was. More than 50% of ne4298ts; pos-1(RNAi) worms 
developed gut at 25°C (Figure 2.6). This suppression was not observed at 15°C. 
  
64
Restoration of gut specification in glp-1(ne4298ts); pos-1(RNAi) embryos 
 
 
 
Figure 2.6 
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Figure 2.6. Embryos from glp-1(ne4298ts); pos-1(RNAi) worms using DIC microscopy. 
Embryos arrest with restored endoderm development (pink triangle) and improved 
pharyngeal differentiation (red arrows).   
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ne4298ts was mapped to glp-1 and by sequencing was shown to harbor a lesion 
that results in an amino-acid substitution (G1031D) in the 4th (of 7) ankyrin repeats. 
Several other glp-1ts alleles exhibit amino acid substitutions in the same ankyrin repeat 
region (including e2141, e2144, bn18 and q231) (Figure 2.7). At least two of these 
apparent loss of function temperature sensitive alleles also suppress the endo-mesoderm 
defect of pos-1(zu148) (Figure 2.7). Interestingly, the temperature sensitivity point for 
endoderm restoration occurs in the maternal gonad hours prior to fertilization suggesting 
that glp-1 activity in the germline can interfere with endoderm specification in pos-1 
mutants much later in the embryo (Figure 2.8). 
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glp-1ts alleles with mutations in ankyrin repeat region suppress pos-1 
 
 
 
 
 
 
Figure 2.7  
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Figure 2.7. (A) A schematic of GLP-1 protein identifying its key structural features. 
Several temperature sensitive loss of function alleles including ne4298 have mutations in 
the ankyrin repeat region.  (B) Two other temperature sensitive loss of function glp-1 
alleles suppress the pos-1 gutless phenotype at 25°C. pos-1(zu148),  pos-1(zu148); glp-
1(e2144ts) and pos-1(zu148); glp-1(e2141ts) hermaphrodites were grown at 15°C (n = 5, 
11 and 6 respectively) and the percentage of gut induction in there progeny was scored 
(blue columns). Siblings from the same genetic backgrounds were upshifted as L4s to 
25°C (n = 5, 11 and 6 respectively) and gut induction in their progeny was scored (red 
coloumns). Error bars reflect standard deviation.   
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Temperature sensitive point (tsp) of glp-1ts suppression is in maternal germline 
 
 
 
 
 
 
 
Figure 2.8  
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Figure 2.8. The temperature sensitivity point of glp-1ts suppression is in the maternal 
germline. (A) Adult glp-1(ne2141ts); pos-1(zu148) worms reared at 15°C (permissive 
temperature) were upshifted to 25°C and embryos were scored for gut development in the 
order they were laid. Endoderm restoration ensues after 10 hours of upshift, indicating 
that the loss of glp-1 function in the developing maternal germ cells and not in the 
embryos suppresses pos-1. (B) glp-1 functions in three different contexts, germline 
proliferation in the distal end of the gonad, P2 to ABp signaling (1st tsp) and MS to AB8 
signaling in the early embryo (2nd tsp). The first context is the site of glp-1 temperature 
sensitive suppression of pos-1.  
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Summary 
pos-1(-) embryos die gutless. To understand why, I conducted an RNAi screen 
using ~1000 genes required for embryonic development to search for suppressors of pos-
1 that would restore gut development. cye-1 and neg-1 were among the strong 
suppressors and were chosen for further study. Immunofluorescent staining did not reveal 
an increase in CYE-1 levels the absence of pos-1, ruling out the hypothesis that cye-1 is a 
gut antagonizer repressed by POS-1. neg-1 is the subject of the following chapter. In 
parallel, glp-1(ne4298ts) was isolated in a forward mutagenesis screen and found to 
suppress pos-1. Interestingly, the temperature sensitive point for gut restoration was in 
the maternal germline hours before the onset of embryogenesis.  
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MATERIALS AND METHODS 
RNAi screen  
Adult pos-1(zu148) unc-42(e270) heterozygous worms were fed E. coli 
HT115(DE3) expressing double stranded RNA targeting a specific gene expressed by the 
C. elegans genome. A quarter of the progeny were pos-1 homozygous worms identified 
by their Unc phenotype. These worms were singled on to fresh plates and their dead 
embryos examined and scored for gut induction; evident by birefringent gut granules 
(Laufer et al., 1980). The screen focused on ~1000 genes essential for embryogenesis. 
Since many of these genes were also required for germline development, prolonged 
exposure to RNAi caused sterility in approximately one quarter of knockdowns. To avoid 
this limitation, pos-1 homozygous worms in the L3 stage were placed on the RNAi food. 
This shorter exposure allowed for the production of examinable progeny. 
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Chapter III  
neg-1  
and its regulation 
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PREFACE 
C13F10.7 was identified as an interactor of NEG-1 in collaboration with Alex 
Tamburino (Laboratory of Marian Walhout, University of Massachusetts Medical 
School, MA).  
Cell-lineaging of neg-1(tm6077) was done in collaboration with Zhuo Du 
(Laboratory of Zhirong Bao, Memorial Sloan Kettering Cancer Center, NY). 
Behavioral assays were done in collaboration with Chris Chute (Laboratory of 
Jagan Srinivasan, Worcester Polytechnic Institute, MA). 
In vitro binding assays between neg-1 3’UTR and MEX-3, MEX-5 and POS-1 
were done in collaboration with Ebru Kaymak (Laboratory of Sean Ryder, University of 
Massachusetts Medical School, MA). 
Extension polyA tail assays were done in collaboration with Traude Beilharz 
(Monash University, Australia) 
GFP tagged neg-1 worm strains and neg-1 3’UTR GFP reporter strains were 
engineered in collaboration with Masaki Shirayama. 
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ABSTRACT 
neg-1 was identified as a suppressor of the pos-1 gutless phenotype. The product 
of this gene is a novel protein with no sequence homology beyond the Caenorhabditis 
genus. Importantly, this gene is required for proper embryogenesis since >70% of neg-1 
knockout embryos die with defects in anterior development.  
neg-1 mRNA is maternally contributed to the embryo where it is expressed in the 
anterior blastomeres ABa and ABp but not the posterior blastomeres EMS and P2. In the 
absence of pos-1 function, neg-1 is ectopically expressed in P2 and EMS. Poly(A) tails of 
neg-1 transcripts in the early embryo are extended beyond wildtype lengths in the 
absence of pos-1 function and are shorter in the absence of gld-3. We hypothesized that 
POS-1 binds the 3’UTR of neg-1 mRNA to block gld-3 mediated cytoplasmic 
polyadenylation and subsequent translation. Indeed, POS-1 binds the 3’UTR of neg-1 in 
vitro as do the anterior blastomere determinants MEX-3 and MEX-5. mex-5(RNAi) leads 
to a loss of neg-1 expression. I propose a model whereby POS-1 guards EMS identity by 
blocking GLD-3 mediated neg-1 expression. Conversely, MEX-5 protects the fate of the 
anterior blastomere AB by countering POS-1 repression of neg-1 expression.  
Characterization of neg-1 function remains preliminary. Interestingly, the 
embryonic lethality of neg-1 is suppressed in neg-1; med-1 double mutants. med-1 is a 
GATA transcription factor implicated in EMS specification and subsequent mesoderm 
and endoderm differentiation. This genetic interaction suggests that neg-1 and med-1 
could be involved in a mutually inhibitive regulatory network that segregates the fates of 
AB and EMS.   
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neg-­‐1 is a suppressor of pos-­‐1
RNAi knockdown of F32D1.6 restored EMS specification and gut development in 
the otherwise gutless pos-1(zu148) genetic background (>95% of pos-1; F32D1.6(RNAi) 
embryos were gut+) (Figure 3.1). We refer to this gene as neg-1 (Negative Effect on 
Gut). Interestingly, two independent groups using single cell transcriptomics have 
demonstrated that F32D1.6 transcripts are enriched in the AB blastomere (Hashimshony 
et al., 2012) (Osborne-Nishimura personal communication). Moreover, F32D1.6 was 
among 968 genes found to be enriched in 13 embryonic motor neurons (unc-4::GFP 
neurons), suggesting an association with neuronal development (Fox et al., 2005). 
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neg-1(-) restores EMS specification and gut development in pos-1(-) embryos 
 
 
 
 
 
 
 
 
 
Figure 3.1 
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Figure 3.1. Birefringent gut granules (pink triangle) are restored in pos-1(zu148); neg-
1(RNAi) embryos. Two GFP markers demonstrate the pos-1 phenotype. ajm-1::gfp 
marker is expressed in cell-cell junctions of hypodermal cells surrounding the embryo. 
pha-4::gfp is expressed in nuclei of pharynx (between red arrows) and intestine (between 
pink triangles). pos-1 embryos have incomplete hypodermis due to misspecification of 
ABp (light blue circle in wildtype) into ABa (blue blastomere). These embryos also lack 
pharynx and intestine due to failure in EMS identity determination (no GFP). neg-1 loss 
of function restores EMS identity and endo-mesoderm differentiation (pharyngeal and 
intestinal development) but does not rescue the hypodermal defect.  
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NEG-1 sequence is poorly conserved 
Local alignment searching using NCBI BLAST revealed a single homologue of 
NEG-1 in the nematode C. brenneri (31% identity, e-value 4x10-07). A second query 
using CBN07554 solely retrieved NEG-1 (33% identity, e-value 5x10-09). However, the 
public nematode database Wormbase annotated the C. japonica protein CJA09859 as a 
homologue of CBN07554 (identity 30%, e-value 2x10-08). Oddly, a third BLAST query 
using CJA09859 did not retrieve CBN07554, but instead detected NEG-1 (34% identity, 
e-value 0.04). A multiple alignment revealed that homology was highest at the C termini 
of these three proteins (Figure 3.2). The three nematode genes encoding NEG-1, 
CBN0775 and CJA09859 reside in corresponding genomic neighborhoods spanning 
approximately 25 kbp and demarcated by the genes grl-13 and the uncharacterized gene 
F13A2.9 (Figure 3.3). Given the sequence homology and the similar genomic location, I 
consider these genes to be homologues. 
The initial BLAST query also retrieved a 7459 amino acid long predicted 
uncharacterized protein from the Acorn worm Saccoglossus kowalevskii. The last subject 
retrieved from the query was a 240 amino acid long hypothetical protein from the protist 
Perkinsus marinus. However, the poor e-value of these results (2.9 and 4.7 respectively) 
discouraged further pursuit. 
BLASTP searches protein sequence databases. On the other hand, Domain 
Enhanced Lookup Time Accelerated BLAST, DELTA-BLAST first searches a database 
of position-specific score matrices (PSSMs) before searching protein sequences (Boratyn 
et al., 2012). This approach allows the recovery of distant homologues that may 
otherwise escape BLAST queries. A DELTA-BLAST query using C. elegans NEG-1 
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identified itself, the C. brenneri homolog and numerous 50S ribosomal subunit 15 
(RPL15) proteins from myriad prokaryotes. Position specific iterated BLAST (PSI-
BLAST) iteratively searches a protein sequence database, using the matches in one round 
to construct a position-specific score matrix (PSSM) for searching the database in next 
round (Altschul et al., 1997). Performing PSI-BLAST by selecting the C. elegans and C. 
brenneri NEG-1 sequences from the first DELTA-BLAST, but not the 50S ribosomal 
protein 15 subjects, retrieved NEG-1 and a mixture of plant 60S and prokaryotic 50S 
ribosomal protein 15 subjects. The identity shared between NEG-1 and these RPL15 
averaged around 20% with an e-value of less than 10-30. Conducting the same DELTA-
BLAST followed by an iteration of PSI-BLAST using the C. brenneri homolog of NEG-
1 did not retrieve RPL15. Instead, the large subunit of DNA-directed RNA polymerase II 
was the main result (identity ~24% and e-value < 10-24.  Despite low e-values, inspecting 
the alignments was not satisfying. Furthermore, this result was not arrived at when 
beginning the query with C. brenneri NEG-1.  
Pattern Hit Initiated BLAST (PHI-BLAST) minimizes false positives by filtering 
those that do not include a predefined amino acid pattern. The C terminus of C. elegans 
NEG-1 and the homologs in C. brenneri and C. japonica share the following pattern 
LGTXXXRXXXLKLM, where X is any amino acid. I therefore used a more flexible 
version of this pattern (LGTX1-10LKLM) to search for further NEG-1 homologs. 
However, this was unfruitful.  
 Furthermore, protein databases Pfam, InterPro and PROSITE detected no motifs 
or conserved region nor affiliation with any known protein family. Moreover, protein 
structure prediction services offered predicted structures with low confidence levels (I-
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TASSER) or declined to predict all together (Phyre) (data not shown). However, NCBI 
Concerved Domains identified a portion of the 50S ribosomal protein L15e domain in 
NEG-1 but not in the C. brenneri or C. japonica homologs (Figure 3.2). 
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Multiple alignment of NEG-1 and two homologs 
 
 
 
 
 
 
 
 
 
Figure 3.2 
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Figure 3.2. (A) Two homologs from C. brenneri (CBN07554) and C. japonica 
(CJA09859) are aligned with NEG-1. The C-terminus exhibits the highest conservation. 
Putative nuclear localization sequences are underlined. (B) A predicted Ribosomal 
protein L15e superfamily domain detected by NCBI Conserved domains.   
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neg-1 and its homologs reside in the same genomic neighborhood 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 
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Figure 3.3. The genomic neighborhood of neg-1 (grey) and its homologs Cbn-neg-1 and 
Cjp-neg-1 is heavily rearranged. Common features of their loci include the presence of 
grl-13 and two adjacent genes (orange). A homolog of fipp-1 (red) is present in near neg-
1 in C. brenneri but not in C. japonica, perhaps due to the contig ending near this region. 
F13A2.9 (blue) and its homologs demarcate one end of the genomic neighborhood. The 
locus in C. brigssae includes all landmarks but not neg-1 homolog. Instead a larger 
predicted gene (CBG23621) resides where neg-1 would be expected. 
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NEG-1 protein exhibits an skewed amino acid distribution 
I noticed a striking asymmetry in the distribution of amino acids in NEG-1 and its 
two nematode homologues (Figure 3.4). Aromatic hydrophobic amino acids tryptophan, 
phenylalanine, and tyrosine were concentrated in the first half of the protein sequence (9 
in the N-terminal half and 2 in the C-terminal half, 9:2) whereas the basic amino acids 
arginine and lysine were concentrated in the second half (3:24). I wondered about the 
prevalence of such sequence asymmetry and searched the C. elegans proteome (WS234) 
for other skewed proteins. A query for proteins that had at least 3 times more aromatic 
hydrophobic residues (W/Y/F) in its N-terminal half and 3 times more basic residues 
(R/K) in its C-terminal half retrieved 41 proteins. Surprisingly, transcription factors 
including endo-mesoderm regulators MED-1, MED-2 and END-3 were over represented 
in this group of proteins with skewed sequences. For example, MED-1 sequence contains 
22 residues of W, Y, or F in the N-terminal half and only 7 in the C-terminal. On the 
other hand, R and K residues do not exist in the N-terminal whereas 15 exist in the C-
terminal half. Extending the query to S. cerevisiae retrieved the bZIP transcription factor 
GCN4. The Fly and Human proteome also include a number of skewed proteins that 
included transcription factors. A list of these results is compiled in Table 3.1. 
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Skewed distribution of aromatic and polar basic amino acids in NEG-1, its 
homologues, MED-1 and C13F10.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 
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Figure 3.4. A diagram showing protein sequences as boxes each representing an amino 
acid. Aromatic amino acids Tryptophan, Tyrosine and Phenylalanine are skewed to the 
N-terminal half (blue). Basic amino acids Lysine and Arginine are skewed to the C-
terminal half (red).   
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Table 3.1. Proteins with skewed WFY/RK distribution (continued in appendix) 
Species Name length
N'
FWY
C'
FWY
FWY
ratio
N'
RK
C'
RK
RK
ratio Functional Annotation
C. elegans B0205.10 455 6 1 6.0 15 49 0.3 Uncharacterized protein
C. elegans B0379.7 409 6 1 6.0 16 49 0.3 Uncharacterized protein
C. elegans C04G6.10 166 5 0 5.0 5 17 0.3 Uncharacterized protein
C. elegans C13F10.7 222 9 0 9.0 11 47 0.2 Putative zinc finger
C. elegans C40H5.2B 115 12 3 4.0 1 6 0.2 Uncharacterized protein
C. elegans D2062.4A 132 13 4 3.3 3 12 0.3 Uncharacterized protein
C. elegans END-­‐1 221 16 5 3.2 1 19 0.1 ENDoderm determining
C. elegans F07C6.2 115 7 2 3.5 1 14 0.1 Uncharacterized protein
C. elegans F11C1.7a 132 7 1 7.0 3 12 0.3 Uncharacterized protein
C. elegans F13H8.5a 439 28 9 3.1 9 29 0.3 Uncharacterized protein
C. elegans F32D1.6 176 9 2 4.5 3 24 0.1 NEG-­‐1
C. elegans F35C5.12 126 14 4 3.5 4 16 0.3 Uncharacterized protein
C. elegans F36D1.7 113 6 0 6.0 1 4 0.3 Uncharacterized protein
C. elegans F42A9.6c 101 16 5 3.2 2 7 0.3 Uncharacterized protein
C. elegans F44F4.9 118 8 2 4.0 6 19 0.3 Uncharacterized protein
C. elegans F55F10.3 181 10 1 10.0 6 21 0.3 Uncharacterized protein
C. elegans F56A11.6 419 18 1 18.0 22 92 0.2 Uncharacterized protein
C. elegans F59B10.6 105 10 1 10.0 2 7 0.3 Uncharacterized protein
C. elegans H12D21.5 160 11 2 5.5 5 20 0.3 Uncharacterized protein
C. elegans HRP-­‐2 108 10 3 3.3 3 11 0.3 human HnRNP A1 homolog
C. elegans JUNE-­‐1E 164 12 1 12.0 2 21 0.1
JUN transcription factor
homolog
C. elegans K02E10.5 132 10 2 5.0 3 10 0.3 Uncharacterized protein
C. elegans K03B4.6 134 10 1 10.0 1 10 0.1 Uncharacterized protein
C. elegans MED-­‐1 174 22 7 3.1 0 15 0.1
Mesoderm and Endoderm
Determination
C. elegans MED-­‐2 174 22 6 3.7 0 14 0.1
Mesoderm and Endoderm
Determination
C. elegans MIG-­‐2 195 11 3 3.7 5 17 0.3 abnormal cell MIGration
C. elegans PQN-­‐75 539 28 4 7.0 9 35 0.3
Prion-­‐like-­‐(Q/N-­‐rich)-­‐
domain-­‐bearing protein
C. elegans RSP-­‐7 452 19 2 9.5 16 92 0.2 SR Protein (splicing factor)
C. elegans SST-­‐20 231 14 3 4.7 1 28 0.0 Sperm Specific Transcript
C. elegans T22C1.4 111 4 1 4.0 2 12 0.2 Uncharacterized protein
C. elegans T25G12.3 204 15 1 15.0 4 23 0.2 Uncharacterized protein
C. elegans Y38H6A.3 247 13 4 3.3 5 16 0.3 Uncharacterized protein
C. elegans Y46G5A.23 108 4 0 4.0 1 8 0.1 Uncharacterized protein
C. elegans Y57G7A.2 177 10 3 3.3 4 17 0.2 Uncharacterized protein
C. elegans Y67D8B.3 119 11 0 11.0 4 15 0.3 Uncharacterized protein
C. elegans Y69A2AR.8b 120 7 0 7.0 1 23 0.0 Uncharacterized protein
C. elegans Y73B3A.1 659 27 7 3.9 18 62 0.3 Uncharacterized protein
C. elegans Y95B8A.2 128 9 1 9.0 2 8 0.3 Uncharacterized protein
C. elegans ZC250.4 103 5 0 5.0 2 7 0.3 Uncharacterized protein
C. elegans ZC416.2 104 9 2 4.5 0 5 0.2 Uncharacterized protein
C. elegans ZIP-­‐11 228 12 3 4.0 4 21 0.2 bZIP transcription factor
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NEG-1 interactors via yeast two hybrid 
In order to gain insight into the role played by NEG-1, I conducted a yeast two 
hybrid screen using NEG-1 as bait and a library of C. elegans cDNA as preys (Walhout 
and Vidal, 2001). The results of this screen are summarized in Table 3.2. Of note are the 
interactions with the bromodomain protein BET-1, which appeared both in the pilot 
screen aimed at optimizing my transformation conditions and in the main screen 
conducted afterwards (Figure 3.5).  
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EEF-1G and BET-1 interact with NEG-1 in a yeast-two-hybrid screen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 
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Figure 3.5. Three selection assays were used to confirm yeast-2-hybrid protein 
interactions: the ability to yeast cells grow in absence of histidine and presence of 40mM 
3-amino-1,2,4-triazole (3-AT), the ability to grow in absence of uracil and the expression 
of LacZ. Red circles identify colonies that scored positive on all three tests, orange circles 
identify colonies that scored positive on two tests only. Tan circles scored positive on –
His 40mM 3AT alone.  
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Table 3.2. Results from NEG-1 yeast-two-hybrid screen 
Bait Prey -His -Ura XGal N Pilot N Annotation 
NEG-1A EEF-1G ✓ ✓ ✓ 7 ✓ 1 
Eukaryotic 
elongation factor 
gamma 
NEG-1A BET-1 ✓ ✗ ✓ 1 ✓ 2 Bromodomain 
protein 
NEG-1A RPL-7 ✓ ✗ ✓ 1 ✗ 0 Ribosomal 
protein 
NEG-1A GPD-2/3 ✓ ✗ ✓ 1 ✗ 0 
Glyceraldehyde  
3-phosphate 
dehydrogenase 
NEG-1A CEY-2 ✓ ✗ ✓ 1 ✗ 0 C. elegans Y-box 
NEG-1A ASP-1 ✓ ✗ ✓ 1 ✗ 0 Aspartyl protease 
NEG-1A ACT-5 ✓ ✗ ✓ 1 ✗ 0 Actin 
NEG-1A PDI-1 ✓ ✗ ✓ 1 ✗ 0 Protein Disulfide 
Isomerase 
NEG-1A COL-152 ✓ ✗ ✓ 1 ✗ 0 Collagen 
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In a parallel effort, we tested if NEG-1 interacts with transcription factors or RNA 
binding proteins by using a direct Y2H mating assay. NEG-1 was used as a prey against 
an array of RNA binding protein baits (Tamburino et al., 2013). In this assay NEG-1 
interacted with C13F10.7, a putative zinc finger with a zinc knuckle domain 
(CX2CX4HX4C where X can be any amino acid) and a protein with skewed sequence 
like NEG-1 (Figure 3.4 and Table 3.1). Interestingly, C13F10.7 interacted with the 
chromodomain protein CEC-8 in a proteome-wide Y2H screen (Li et al 2004). Moreover, 
in a computational study, C13F10.7 is predicted to interact with histone acetyl-
transferases MYS-1 and MYS-2 (Zhong and Sternberg, 2006). mys-1/2 have recently 
been shown to affect the nuclear localization of BET-1 (Shibata et al., 2010). 
We also used NEG-1 as a bait against an array of transcription factors as preys 
(Reece-Hoyes et al., 2011). No interactions were detected from this assay. 
Taking together, our yeast two hybrid screens and previous published physical 
and predicted interactions. NEG-1 appears to be nested in a network of interactions 
related to chromatin remodeling (Figure 3.6).  
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The putative zinc finger C13F10.7 is a NEG-1 interactor and interacts with 
chromatin remodeling factors 
Figure 3.6 
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Figure 3.6. (A) C13F10.7 is a putative CCHC zinc finger with no known function. (B) 
Yeast two hybrid screens suggest that NEG-1 physically interacts with bromodomain 
protein BET-1 and the C13F10.7 (green). Additional protein interaction (orange edges), 
predicted functional interactions (black edges) and experimentally validated functional 
interactions (arrows) are shown.  
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Characterization of neg-1 loss of function 
We obtained a knockout allele of neg-1 that removed a region encoding the last 
97 amino acids. The deletion also removed the terminating stop codon of the gene thus 
fusing the coding region with the 3’UTR and adding 11 codons to the predicted gene 
product before encountering an in-frame stop codon (Figure 3.7).  Similar to neg-
1(RNAi), neg-1(tm6077) restored endoderm specification in pos-1 dead embryos (97%). 
Furthermore, neg-1(tm6077) was essential for embryonic development as 79% of neg-
1(6077) embryos died before hatching with defects in anterior morphogenesis (Figure 
3.7). Whereas the posterior half of neg-1 embryos enclose and elongate, the anterior does 
not, due to incomplete hypodermal development. Furthermore, in 11% of dead embryos, 
a Glp-like incomplete pharynx was observed (data not shown). 
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neg-1 is required for embryogenesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7  
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Figure 3.7.  (A) The neg-1 gene consists of five exons (black boxes) and a long 
annotated 3’UTR (white). The region deleted by tm6077 is shown. (B) More than 75% of 
neg-1(tm6077) embryos die during embryogenesis. (C) neg-1 dead embryos exhibit 
anterior morphological defects.   
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The mesoderm marker pha-4 is misexpressed in neg-1 mutant embryos 
The expression of FoxA transcription factor pha-4 serves as a marker for 
mesoderm development (Horner et al., 1998). We noticed that pha-4 was inappropriately 
expressed in the anterior AB lineage (Figure 3.8). In wildtype embryos only two of the 
eight AB granddaughters (ABalp and ABara) express a mesoderm fate in response to MS 
induction. In apx-1 mutants, three additional AB granddaughters ABpra, ABprp and 
ABplp also express a mesoderm fate in response to MS induction (Mello et al., 1994). 
However, in neg-1(6077) embryos, the ABala, ABarp and ABpla granddaughters express 
pha-4. This means that three additional AB granddaughters express a mesoderm fate, but 
intriguingly are not the three granddaughters that undergo the Apx misspecification. 
Therefore, the neg-1 embryos exhibit ectopic mesoderm differentiation in the AB lineage 
different from that observed in Apx embryos and more in tune with a subtle Mex 
phenotype.  
In addition to this gain of ectopic expression, pha-4 is also reduced in the ABalp 
and ABara that normally express this marker in wildtype embryos (Figure 3.8).  
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The mesoderm marker pha-4 is misexpressed in neg-1 mutant embryos. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 
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Figure 3.8. PHA-4::GFP (solid red) is expressed in the ABalp and ABara lineages of 
wildtype embryos. neg-1(tm6077) embryos ectopically express pha-4 in ABala, ABarp 
and ABpla lineages. Wildtype embryos express pha-4 in the anterior sublineage of 
ABalp. neg-1(tm6077) exhibit a gain of pha-4 expression in the posterior sublineage of 
ABalp (2/4) or a loss of expression in both sublineages (1/4). ABara expresses pha-4 in 
both anterior and posterior sublineages. ABara pha-4 expression is reduced in neg-
1(tm6077). Numbers reflect the number of times pha-4::gfp expression was detected in a 
given cell in a lineaged embryo.   
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neg-1 worms exhibit behavioral defects 
Since neg-1 embryos exhibit defects in anterior ectoderm development including 
ectopic mesoderm differentiation, I wondered if the embryos that do hatch lived with a 
defective nervous system. Such a subtle defect would not be lethal but would alter 
behavior. No gross behavioral defects are observed in neg-1 adults. However, a 
systematic behavioral survey revealed a defect in osmotic avoidance. 
The glycerol drop test is a behavioral assay that tests osmotic avoidance. In this 
assay, a drop of glycerol is delivered near the tail of a worm as it moves forward. The 
glycerol drop instantly surrounds the worm and reaches the anterior sensory organs. 
Wildtype worms immediately sense the glycerol as a repellent and start moving 
backward. However, neg-1 larvae showed an approximately 2-fold decrease in their 
avoidance index compared to wildtype worms (Figure 3.9).  
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neg-1 worms are defective in osmotic avoidance 
Figure 3.9 
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Figure 3.9. Glycerol avoidance assay. A drop of glycerol is delivered near the tail of a 
worm as it moves forward. Wildtype respond by moving backwards, which is considered 
a positive response. The avoidance index is the number of positive responses divided by 
the total number of trials (n = 40 trails per genotype stage). Deionized water (di). Error 
bars are standard error of the mean. 
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NEG-1 is asymmetrically expressed in the early embryo 
In order to investigate the spatial-temporal expression of NEG-1, we engineered a 
neg-1::gfp transgenic worm using MosSci transgenesis (Frokjaer-Jensen et al., 2008) and 
found that its expression was patterned in the early embryo (Figure 3.10). NEG-1::GFP 
was detected in the zygotic nucleus and at equal levels in both nuclei of the two cell stage 
embryo (23/23). At the four-cell stage, NEG-1::GFP expression was higher in nuclei of 
the anterior ABa and ABp blastomeres compared to the nuclei of EMS and P2 (31/34). 
Following the four-cell stage, NEG-1::GFP was detected in the granddaughters of the AB 
blastomere and to a lesser degree in the great granddaughters before henceforth going 
undetected (data not shown). We also observed NEG-1::GFP in the nuclei of distal germ 
cells as well as nuclei of maturing oocytes Figure 3.10. We also noticed an intense sub-
nucleur localization of NEG-1:GFP suggesting its localization along condensed 
chromatin (Figure 3.10).  
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NEG-1 is asymmetrically expressed in the early embryo and co-localizes with 
chromatin 
 
 
 
 
 
 
 
Figure 3.10 
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Figure 3.10 continued 
Figure 3.10. (A) NEG-1::GFP is detected in the both nuclei in the two-cell stage but only 
in ABa and ABp in the 4 cell stage. pos-1(RNAi) embryos show NEG-1::GFP expression 
in all four cells. NEG-1::GFP expression is lost in gld-3(RNAi) embryos. (B) Subnuclear 
NEG-1::GFP localization is most intense along chromatin. (C) NEG-1::GFP is expressed 
in germline with localization restricted to distal germ cells and maturing and mature 
oocytes. (D and E). GFP::neg-1 3’UTR reporter recapitulates asymmetric expression of 
NEG-1::GFP. Arrows highlight asymmetric expression in 4-cell stage. (#) highlight 
expression in early embryos (AB8 and AB16 stages), whereas (*) highlight lack of 
expression in later embryos (post AB16 stage).   
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neg-1 asymmetric expression is dependent on pos-1 and gld-3  
To test our prediction that neg-1 is a target of POS-1 repression, we examined the 
effect of pos-1 knockdown on NEG-1 localization. Ectopic NEG-1::GFP was observed in 
the posterior blastomeres EMS and P2 upon pos-1 RNAi (14/14) (Figure 3.10). A similar 
effect was observed in the pos-1(zu148) background (6/6). Our initial model postulated 
that the production of NEG-1 would be dependent on GLD-3 and GLD-2. No NEG-
1::GFP was detected in the nuclei of one-cell or two-cell stage embryos following gld-3 
RNAi (0/7 and 0/11 respectively) (Figure 3.10). During the four-cell and 6-to-8 cell 
stages, weak NEG-1::GFP could be detected in the AB lineage but not in that of P1 (4/11 
and 6/12 respectively). The same loss of embryonic NEG-1::GFP was observed following 
gld-2 RNAi, albeit to a lesser degree (2-cell: 4/14, 4-cell: 6/8, 6-to-8 cell: 4/5). However, 
this difference is likely due to shorter exposure to gld-2 dsRNA, intentionally curtailed to 
avoid sterility. Taken together, we conclude that pos-1 down-regulates the expression of 
NEG-1 in posterior blastomeres and that gld-3 and gld-2 are required for the expression 
of neg-1 during the one- and two-cell stages and partially thereafter. 
gld-3 is downstream of pos-1 in the regulation of neg-1 expression 
Importantly, pos-1(zu148) worms expressing neg-1::gfp and growing on gld-3 
RNAi food developed embryos with no NEG-1::GFP expression (0/6). This means that 
with regards to neg-1 expression, loss of both pos-1 and gld-3 resemble the phenotype of 
gld-3 and that gld-3 is therefore downstream of pos-1 in the regulation of neg-1 
expression. 
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neg-1 mRNA in early embryos have shorter poly(A) tails after gld-3 or gld-2 
knockdown but longer tails after pos-1 knockdown 
Since NEG-1::GFP is reduced in gld-3(RNAi) and gld-2(RNAi) embryos, we 
asked if gld-3 and gld-2 were required for the polyadenylation of neg-1 mRNA. Several 
C. elegans transcripts expressed in the germline have been shown to be dependent on 
GLD-2 for their polyadenylation, which in turn precedes translation activation (Janicke et 
al., 2012; Kim et al., 2010). We assayed the length of neg-1 poly(A)-tails using extension 
Poly-A Test (ePAT), which allows an efficient and rapid assessment of poly(A)-tail 
lengths with a sensitivity comparable to Northern blots but without the need of 
radiolabeled probes (Janicke et al., 2012). 1µg of total RNA isolated from wild-type (N2), 
pos-1(RNAi), gld-3(RNAi) or gld-2(RNAi) early embryos was subjected to ePAT. 
Compared to neg-1 mRNA from wildtype worms, the range of poly(A) tail length was 
longer in and pos-1(RNAi) early embryos and shorter after gld-3 and gld-2 knockdown 
(Figure 3.11).  
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neg-1 poly(A) tail is affected by pos-1 and gld-3/2 
 
 
 
 
Figure 3.11 
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Figure 3.11. (A) Extension Poly(A) Test. 1µL of PAT anchor 5′-
GCGAGCTCCGCGGCCGCGTTTTTTTTTTTT  (green) is added to 1µg of total RNA 
and Klenow Polymerase extends the poly(A)tail with a sequence complementary to the 
anchor (purple). Reverse transcription using a primer (red) that recognizes the extension 
(purple) is conducted to obtain cDNA. Then, 25 cycles of PCR amplification using a 
3'UTR specific forward primer (blue) amplifies the poly(A) tails.  (B) Smears reflect the 
extent of neg-1 poly(A) tail length in each genetic background. The range of neg-1 
poly(A)-tails is longer in pos-1(-) early embryos and shorter in gld-3(RNAi) or gld-
2(RNAi) early embryos. RNA was isolated by Ahmed Elewa ePAT reaction and gel were 
done by Traude Beilharz.  (C) A model of pos-1 repression of neg-1 expression: POS-1 
binds the 3’UTR of neg-1 and prevents GLD-3/2 dependent polyadenylation. (D) A 
genetic pathway for EMS specification: pos-1 represses gld-3, which promotes neg-1, 
which in turn inhibits EMS specification. (F) ePAT provides a semi-quantitative readout 
for poly(A)-tail length. The intensity of smears in (B) was quantified using LabWorks gel 
documentation software. Intensity curves were overlaid in comparison to a 100bp ladder 
(grey). Poly(A)-tails from pos-1(RNAi) embryos (green) exhibit a longer range of 
intensity compared to poly(A)-tails from wildtype (yellow). Conversely, poly(A)-tails 
from gld-3(RNAi) (purple) or gld-2(RNAi) embryos (blue) exhibit a shorter range of 
intensity.  
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The 3’UTR of neg-1 is sufficient to confer asymmetric expression in the early 
embryo 
3’ untranslated regions regulate the majority of patterned gene expression in the 
germline and early embryo (Merritt et al., 2008). To confirm that the asymmetric 
expression of NEG-1::GFP was regulated by the neg-1 3’UTR, we expressed GFP with a 
nuclear localization sequence under the promoter of oma-1 and the 3’UTR of neg-1. 
Expression under the oma-1 promoter allows for germline transcription of the gfp::neg-1 
3’UTR, the transcripts of which would be deposited in oocytes. We observed a pattern of 
GFP expression in the early embryo identical to that of NEG-1::GFP (Figure 3.10). We 
therefore conclude that the 3’UTR of neg-1 is sufficient to confer asymmetric expression 
in the early embryo. 
POS-1, MEX-3 and MEX-5 bind the 3’UTR of neg-1 in vitro 
The 3’UTR of neg-1 includes a cluster of 3 overlapping predicted RNA binding 
protein (RBP) elements, referred to here as the RBP cluster. This RBP cluster begins with 
a uracil rich sequence that qualifies as a MEX-5 binding region and which becomes part 
of overlapping MEX-3 and POS-1 predicted binding elements (Farley et al., 2008; 
Pagano et al., 2009; Pagano et al., 2007). To address whether these proteins physically 
bind to the RBP cluster we conducted electrophoretic mobility shift (EMSA) and/or 
fluorescence polarization (FP) assays to determine their affinity to this sequence. POS-1, 
MEX-3 and MEX-5 bind the RBP cluster  (Kd,app = 76 nM,  40nM and 88 nM 
respectively). These affinities are comparable to those determined between each protein 
and confirmed biological targets. Mutating the MEX-3 or POS-1 binding elements 
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prevented their corresponding proteins from interacting (Kd,app = 532 and >1000 nM 
respectively) (Figure 3.12).  
A second MEX-5 binding region (M5FW) is predicted to exist upstream of the 
RBP cluster. MEX-5 interacted with this region with an affinity of Kd,app = 125 nM. An 
additional POS-1 binding element overlapping with a MEX-3 consensus sequence is 
predicted to reside downstream of the RBP cluster (OLWT). However, neither site 
showed binding to its corresponding protein in vitro (Table 3.3).  A summary of 
interactions is presented in Figure 3.13. 
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POS-1, MEX-3 and MEX-5 bind the neg-1 3’UTR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12 
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Figure 3.12. Predicted binding sites for POS-1 (grey), MEX-3 (orange) and MEX-5 (red) 
are mapped onto the neg-1 3’UTR. Predicted polyadenylation signals are in purple 
hexagons. The RBP cluster includes overlapping sites of the three proteins. 
Electrophoretic mobility shift assay gels demonstrate that MEX-3 and POS-1 bind the 
RBP cluster in vitro. This binding is lost upon mutating their predicted binding sites.  
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Table 3.3. Summary of in vitro binding assays between POS-1, MEX-5, MEX-3 and 
the neg-1 3’UTR 
Protein RNA Sequence Assay Ave Kd,app (nM) SD N 
POS-1 RBPc WT auuuauuuuuaguuuauuauugacucuguu EMSA 76 35 5 
POS-1 RBPc Mut auuuauuuuuaCCCCCCCCCCCacucuguu EMSA >1000 n/a 3 
POS-1 OLWT uaagcuggauauuuauaguuuaaacgucaa EMSA >1000 n/a 1 
POS-1 RBPc WT auuuauuuuuaguuuauuauugacucuguu FP 59 6 3 
MEX-3 RBPc WT auuuauuuuuaguuuauuauugacucuguu EMSA 37 5 6 
MEX-3 RBPc Mut auuuauuuuuaCCCCCCCCCCCacucuguu EMSA 532 28 3 
MEX-3 OLWT uaagcuggauauuuauaguuuaaacgucaa EMSA 1018 n/a 2 
MEX-3 RBPc WT auuuauuuuuaguuuauuauugacucuguu FP 117 19 6 
MEX-3 RBPc Mut auuuauuuuuaCCCCCCCCCCCacucuguu FP 530 28 3 
MEX-3 OLWT uaagcuggauauuuauaguuuaaacgucaa FP >1000 n/a 3 
MEX-5 M5FW agucgcuuauuuuuuauguauaucg FP 125 6 3 
MEX-5 RBPc WT auuuauuuuuaguuuauuauugacucuguu FP 88 60 3 
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Summary of Protein-RNA interactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13 
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Figure 3.13. A diagram summarizing in vitro assays confirming the MEX-5 (red), MEX-
3 (orange) and POS-1 (grey) interact with the 3’UTR of neg-1. Dissociation constants are 
averaged and rounded from both EMSA and FP assays.   
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mex-5 but not mex-3 is required for neg-1 expression in the early embryo 
The binding of MEX-5 and MEX-3 to the neg-1 3’UTR raised the question of 
whether these proteins are required for neg-1 expression. mex-3(RNAi) had no affect on 
the NEG-1::GFP expression in the one and two-cell stages (2/2 and 9/9 respectively). 
Furthermore, the asymmetric expression of NEG-1::GFP during the four-cell stage was 
similar to that observed in wildtype embryos (9/9). However, NEG-1::GFP was lost upon 
mex-5 knockdown (0/30) (Figure 3.14). 
mex-5 is upstream of pos-1 in the regulation of neg-1 expression 
Loss of NEG-1 expression in mex-5(RNAi) early embryos is opposite to the 
consequence of pos-1 loss of function, whereby NEG-1::GFP is observed in all four cells 
of the 4-cell stage. mex-5 knockdown in a pos-1(zu148); neg-1::gfp background resulted 
in an NEG-1::GFP expression pattern identical to that observed upon loss of pos-1 
function alone. All pos-1(zu148); mex-5(RNAi) early embryos expressed NEG-1::GFP 
(10/10) and 4 out of 4 embryos at the 4-cell stage showed NEG-1::GFP expression in all 
four cells. Therefore, pos-1 is epistatic and genetically downstream to mex-5 in the 
regulation of neg-1 expression (Figure 3.14).  
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mex-5 positively regulates neg-1 expression  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14 
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Figure 3.14. (A) NEG-1::GFP is observed equally in all four cells of pos-1(RNAi) 
embryos. mex-3(RNAi) does not affect neg-1 expression pattern. mex-5(RNAi) prevents 
NEG-1::GFP expression. pos-1(RNAi); mex-5(RNAi) embryos express NEG-1::GFP 
equally in all four cells. (B) mex-5 is upstream of pos-1 in the regulation of neg-1 
expression and functions to counter pos-1 repression.   
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neg-1 lethality is suppressed by loss of med-1 function 
The ectopic pha-4 expression observed in the AB lineage suggests inappropriate  
mesoderm differentiation. To test if this was the cause behind neg-1 embryonic lethality 
we built a neg-1; med-1 double mutant. med-1 is a key endo-mesoderm transcription 
factor that acts downstream of SKN-1 and upstream of END-3, an endoderm promoting 
transcription factor. med-1(ok804) knockout worms are viable. It is only in conjunction 
with loss of med-2 function that endo-mesoderm differentiation is impaired (Maduro et 
al., 2001). neg-1; med-1 double mutants showed a dramatic reduction in embryonic 
lethality (Figure 3.15). The percentage of dead embryos in the double mutant was 
reduced to 35.6% compared to 76.2% in neg-1(tm6077). Therefore, med-1 is a suppressor 
of neg-1 embryonic lethality.  
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neg-1 embryonic lethality is reduced by med-1 loss of function 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 
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Figure 3.15.  neg-1 embryonic lethality is reduced from 76.2% to 35.6% of neg-
1(tm6077); med-1(ok804) embryos. L4 hermaphrodite worms were singled and their 
progeny scored for embryonic lethality. N = number of hermaphrodites assayed. Error 
bars reflect standard deviation (6% and 13% respectively).   
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Model: neg-1 expression is restricted by MEX-5 and POS-1 to the anterior 
blastomere lineage where it protects ectoderm fate by repressing endo-
mesoderm differentiation.
Three lines of evidence suggest that neg-1 is a repressor of endo-mesoderm fate. 
First, the mesoderm transcription factor pha-4 is ectopically expressed in AB sublineages 
that normally differentiate into ectodermal fates (neurons and hypodermis). Second, the 
embryonic lethality of neg-1 is suppressed by loss of med-1 function, a primary 
mesoderm transcription factor. Third, ectopic neg-1 expression in pos-1 mutants 
represses endo-mesoderm fate of the EMS blastomere rendering pos-1 embryos gutless. 
Overexpression of med-1 restores endo-mesoderm differentiation.  
neg-1 may be considered a protector of ectoderm fate for two reasons. First, neg-
1(-) embryos die with defects in anterior development suggesting poor ectoderm 
differentiation and surviving worms exhibit behavioral defects indicative of neuronal 
mal-development. The lethality is reduced in the neg-1; med-1 double mutant. Second, 
neg-1 is normally expressed in the AB lineage, which gives rise to ectodermal cells and it 
is in that context that neg-1 performs its essential mesoderm repressing function.  
neg-1 expression in the anterior blastomere AB and its descendants is promoted 
by MEX-5, which can bind the neg-1 3’UTR and counter POS-1 repression. POS-1 in 
turn represses neg-1 expression in posterior blastomeres EMS and P2 by preventing 
GLD-3/2 mediated polyadenylation of neg-1 transcripts and thereby guards the endo-
mesoderm fate of EMS (Figure 3.16). 
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Model of neg-1 regulation and function 
 
Figure 3.16 
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Figure 3.16. (A) The genetic regulation of neg-1 expression. mex-5 repression of  pos-1 
repression allows gld-3 to positively regulate neg-1. neg-1 expression represses the endo-
mesoderm fate. (B) Molecular regulation of neg-1 expression. MEX-5, MEX-3 and POS-
1 bind the 3’UTR of neg-1. POS-1 prevents GLD-3/2 polyadenylation of neg-1 and 
MEX-5 counters POS-1 repression. NEG-1 represses endo-mesoderm differentiation in 
anterior blastomeres. (C) NEG-1 protects ectoderm fate by repressing endo-mesoderm 
differentiation in AB lineage. MEX-5 both promotes neg-1 and represses skn-1 
expression. SKN-1 protein is therefore reduced in AB daughter cells. Although SKN-1 is 
present in P2, transcription repressor PIE-1 represses the activation of somatic 
differentiation genes. (D) In the zygote P0, MEX-5 counters POS-1 repression and GLD-
3/2 elongate neg-1 poly(A) tails (A(>100)). (E) In the 2 cells stage, high MEX-5 and low 
POS-1 levels ensure neg-1 expression in AB. It is not clear if GLD-3/2 act on neg-1 in 
AB or if transcripts have extended poly(A) tails from the zygote stage, or if new GLD-3 
independent polyadenylation occurs. neg-1 transcripts with extended poly(A) tails from 
the zygote stage and/or residual MEX-5 may explain NEG-1 expression in P1 where 
POS-1 is expressed.  (F) At the four cells stage high MEX-5 levels and no POS-1 ensure 
neg-1 expression in the AB daughter cells. High POS-1 levels in EMS and P2 prevent 
new polyadenylation and continue to repress neg-1 expression despite the presence of 
GLD-3/2. A background level of poly(A) deadenylation and/or mRNA turnover may 
explain why neg-1 transcripts with tails elongated in the zygote stage are no longer 
expressed.   
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MATERIALS AND METHODS 
neg-1::gfp strain construction 
A region of cosmid F32D1 flanked by AflII and NotI digestion sites was subcloned and 
an ORF encoding GFP was introduced upstream of F32D1.6 (neg-1). The engineered 
transgene preserved neg-1 in its predicted operon and its downstream neighbor fipp-1 and 
was introduced using MosSci transgenesis (Frokjaer-Jensen et al., 2008).  
Cloning and of purification of POS-1 80-180 and MEX-5 236-350 
Cloning and purification of recombinant POS-1 and MEX-5 was done as described in 
(Farley et al., 2008) and (Pagano et al., 2007) respectively.  
Preparation of fluorescein-5-thiosemicarbazide labeled RNA 
All RNA oligonucleotides used in this study were chemically synthesized and 
fluorescently labeled with fluorescein-5-thiosemicarbazide by Integrated DNA 
Technologies (IDT).  
Fluorescent electrophoretic mobility shift and fluorescence polarization 
assays 
Fluorescent EMSA and florescence anisotropy assays using recombinant POS-1 and 
MEX-5 and calculation of the apparent dissociation constant was done as described in 
(Farley et al., 2008) and (Pagano et al., 2007) respectively. 
Protein sequence analysis 
Using PERL programing, the number of W, F, Y, R and K residues in the each protein 
over 100 amino acids long and present in the C. elegans proteome (WS234) were 
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counted. The number of W, Y, and Fs in the N-terminal half was divided by the count in 
the C-terminal half. The reverse was done for R and K. Proteins with 3-fold or more 
WYF in the N-terminus and 3-fold or more R and K in the C-terminus were considered 
“skewed proteins”.  The same process was repeated with proteomes of S. cerevisiae, D. 
melanogaster and H. sapiens. 
Yeast 2 Hybrid 
Yeast-2-hybrid was done as described in (Walhout and Vidal 2001). Briefly NEG-1A-DB 
was constructed using Gateway technology. 2x10-6 yeast colonies were screened on –Leu 
–Trp –His +40mM 3AT upon transformation with a C. elegans AD-cDNA library (Gift 
from Laboratory of Marian Walhout, UMass Medical School). Growing colonies were 
retested on –Leu –Trp –His +40mM 3AT, -Uracil plates and by x-Gal staining to test for 
LacZ expression.   
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Chapter IV 
Summary,  
Conclusions and Discussion 
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The importance of repressing alternative identities during blastomere 
specification 
The transition from totipotency to pluripotency is a literal reduction in potential 
fates. During nematode embryogenesis, the transition from germline totipotency to 
somatic stem cell pluripotency requires restricted expression of fate determinants. 
Classical C. elegans mutants with blastomere identity mishaps such of Pharynx and 
Intestine in Excess (pie-1) or Muscle EXcess (mex-5/6 and mex-3), involve a repressor 
restricting the expression of a master transcription factor that activates a differentiation 
program (skn-1 or pal-1). Here I describe a new theme: a translational repressor 
restricting the expression of a fate antagonist.  
In the case of somatic stem cell EMS, SKN-1 promotes the endo-mesoderm fate. 
Yet the potential is not realized unless POS-1 represses neg-1, an endo-mesoderm 
antagonist. On the other side of the embryo where ectodermal differentiation occurs, 
MEX-5 represses SKN-1. In mex-5(-) embryos the anterior ectoderm lineage transforms 
to mesoderm due to ectopic SKN-1. I propose that this is not the only reason and that 
failure to express the mesoderm antagonist neg-1 is also responsible. Similarly, the P2 to 
EMS transformation in pie-1(-) embryos has been attributed to ectopic SKN-1 activity. 
However, I propose that this transformation would not occur without POS-1 faithfully 
repressing neg-1 expression. Indeed, pie-1(-); pos-1(-) embryos die with P2 transforming 
to an EMS that does not differentiate (Craig Mello personal communication). neg-1 
activity also explains the intriguing observation that reducing pos-1 levels suppresses the 
excess muscle in mex-5(-) embryos, which become viable in a pos-1 heterozygous 
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background (Tenlen et al., 2006). POS-1 reduction may increase neg-1 expression in the 
zygote, which would then repress mesoderm differentiation in the anterior lineage.  
Form this interplay of determinants and antagonists it seems that the switch from 
germline to a somatic fate involves three requirements: 
1) Cessation of germline identity, 
2) Positive adoption of a somatic identity, 
3) Repression of antagonists to adopted identity and/or repression of alterative 
somatic identities. 
The classical mutants pie-1, mex-3 and mex-5 have been interpreted in light of the 
first two requirements. pos-1 mutants illuminate the consequences of failing the third 
requirement.  
POS-1 and regulation of posterior lineages 
EMS is not the only blastomere affected in pos-1(-) embryos. Anterior pharyngeal 
development from ABp and the germline blastomere P4 are also affected. It is reasonable 
to think that POS-1 regulates the expression of many maternal transcripts that affect these 
three blastomeres. Exactly how many would require transcriptome wide analyses to 
identify transcripts that (1) have a different poly(A) tail length, (2) change in abundance 
in the absence of POS-1, or (3) are not translated in the absence of POS-1. Based on the 
presence of POS-1 binding elements, 2902 transcripts are predicted to be POS-1 targets, 
227 of which are expressed in the early embryo (Farley et al., 2008). 
In order to gain further insight into the role of pos-1 in regulating early 
embryogenesis, we are conducting a transcriptome-wide ePAT analysis to identify 
transcripts affected by loss of pos-1. Several questions could be answered using this data 
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set. For example, those transcripts that behave similar to neg-1 (longer poly(A) tails) will 
be knocked down by RNAi to examine whether they are required for embryogenesis or 
whether they can correct any of the defects observed in  pos-1(-) embryos.  
It is not known why P2 to ABp signaling fails in pos-1(-) embryos. The regulation 
of neg-1 encourages the hypothesis that mex-5 represses an AB fate antagonist, which is 
promoted by pos-1 to protect posterior lineages. In pos-1(-) embryos this antagonist is 
ectopically expressed in the zygote, AB and/or its daughters where it undermines the 
effect of P2 signaling. In fact, this proposed antagonist may be the cause behind failed 
MS to AB8 signaling. In other words, one third of pos-1(-) embryos may fail to develop 
anterior pharynx not because P2 and MS fails to signal, but because the AB lineage fails 
to respond. 
glp-1/Notch, cye-1/Cyclin E and maternal physiology affecting the behavior of 
offspring.  
The manner in which glp-1 suppresses pos-1 is quite interesting. By perturbing 
glp-1 function in the maternal germline, these germ cells later proceed to become 
embryos that can develop gut even though pos-1 is absent. A simple explanation could be 
that maternal neg-1 expression is glp-1 dependent. At restrictive temperature, neg-1 
expression is reduced in germ cells. When these germ cells become gametes and then 
zygotes, the reduced neg-1 level is not hazardous to EMS specification. Thus embryos 
from glp-1ts moms could specify endo-mesoderm identity without the protection of POS-
1. This may also explain why reducing the activity of transcription factors efl-1ts and dpl-
1ts in the maternal germline restores endo-mesoderm development in pos-1(-) embryos 
(Tenlen et al., 2006).  
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cye-1/CyclinE functions with glp-1 in the germline to promote germ cell 
proliferation and maintain the mitotic zone (Biedermann et al., 2009; Fox et al., 2011; 
Jeong et al., 2011). cye-1 suppression of pos-1 may be a due to reduced neg-1 expression 
in the germline, which then reduces the extent of endo-mesoderm repression in the 
embryo. However, it remains to be discerned whether cye-1 suppression stems from its 
reduction in the embryo or the germline. Anecdotally, onset of cye-1 supression of pos-1 
is delayed compared to gld-3 suppression (24h compared to 9h on RNAi food). This may 
be explained by cye-1 suppression taking place in the germline the same way glp-1 does, 
whereas gld-3 suppression takes place in the embryo. I am currently testing whether 
germline NEG-1::GFP levels are affected in the glp-1ts and cye-1(RNAi) backgrounds. 
  The behavioral defect observed in neg-1 worms brings to our attention the 
behavioral consequences of maternal mal-nutrition or disease. mRNA transcripts loaded 
into the embryo are affected by the state of the maternal germline. While perturbed levels 
of key factors such as neg-1 mRNA may not abort embryogenesis, subtle neuronal 
deficiencies may occur. An exciting possibility is that starved worms produce embryos 
that develop their nervous system differently than progeny of well-fed worms. This 
difference may be the simple consequence of leaky mesoderm differentiation that impairs 
neuronal development. Embryonic endoderm may also be influenced by the state of the 
maternal germline. The same reduced neg-1 that would impair neuronal development 
may allow for more robust endo-mesoderm differentiation. Many possibilities exist and 
the biological dots await our connections.  
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What is neg-1? 
How NEG-1 represses endo-mesoderm genes is still unclear. However, its nuclear 
localization along chromatin suggests a role in gene regulation. Due to its lack of 
homology, predictable tertiary structure and disorganized nature, traditional methods of 
protein sequence analysis have not been useful in recognizing this gene or its protein 
product. In fact the norm seems to be that critical components of the transcriptional 
apparatus such as transcriptional activation factors, co-activators, chromatin remodelers 
and core-promoter factors lack obvious domains, motifs or structures (Levine et al., 
2014). I have presented the skewed sequence of NEG-1 as a distinctive characteristic that 
is common with a number of transcription regulation factors. There exists a literature 
concerned with proteins with such “compositionally biased regions” (CBRs) (Wootton, 
1994; Wootton and Federhen, 1996). Interestingly, more than one third of proteins 
include at least one CBR, which are usually neglected in favor of structured identifiable 
regions. NEG-1, however, does not offer us this distraction. The skewed presence of 
aromatic amino acids W, F and Y in the N-terminal half and of basic amino acids R and 
K in the C-terminal half may be the rudiments of a protein structure. DNA binding 
domains are rich in basic amino acids and proteins frequently utilize hydrophobic 
domains to interact with other proteins. Importantly, several forms of cancer involve the 
translocation of a low complexity domain to a variety of different DNA-binding domains.  
One possibility is that neg-1 is a product of horizontal gene transfer from a different 
organism. Using DELTA-BLAST, an algorithm more sensitive to distant homology, 
NEG-1 is homologous with ribosomal subunit 15 in myriad plants and to lesser degree 
parasitic protozoa. However, performing a similar search using the C. brenneri homolog 
137
of NEG-1 suggests a region homologous to the large subunit of RNA polymerase II. An 
intriguing possibility could be that a foreign RPL15 or RNA Pol II gene (or a fusion of 
both) was incorporated into an ancestral nematode genome and transmitted to subsequent 
generations. Interestingly, RPL15 is overexpressed in forms of gastric and esophageal 
cancer(Hsu et al., 2011; Wang et al., 2006a; Zhang et al., 2004). Whether neg-1 
originates from a foreign RPL15 detrimental to gut development and homeostasis or 
whether its residual RNA polymerase resemblance allows it to interfere with bona fide 
transcription is highly speculative. However, excavating the embryo to discover the logic 
of life has never ceased to surprise.  
 
 
Carnarvon: Can you see anything? 
Carter: Yes, it is wonderful!1 
  
1 Lord Carnarvon and Howard Carter at the tomb of King Tutankhamen on November 
26th 1922, Valley of the Kings, Egypt. 
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Table 3.1. continued 
Species Name length
N'
FWY
C'
FWY
FWY
ratio
N'
RK
C'
RK
RK
ratio Functional Annotation
S. cerevisiae YEL009C 281 13 3 4.3 8 28 0.3
General control protein
GCN4
S. cerevisiae YER190C-­‐A 191 5 1 5.0 1 5 0.2 Uncharacterized protein
S. cerevisiae YPL283W-­‐A 191 5 1 5.0 1 5 0.2 Uncharacterized protein
S. cerevisiae YMR135W-­‐A 177 15 1 15.0 6 25 0.2 Uncharacterized protein
S. cerevisiae YGR296C-­‐A 191 5 1 5.0 1 5 0.2 Uncharacterized protein
S. cerevisiae YJR023C 133 13 4 3.3 0 11 0.1 Uncharacterized protein
S. cerevisiae YML133W-­‐A 191 5 1 5.0 1 5 0.2 Uncharacterized protein
S. cerevisiae YMR123W 122 11 2 5.5 1 13 0.1
V-­‐type ATPase assembly
factor PKR1
S. cerevisiae YNL339W-­‐A 191 5 1 5.0 1 5 0.2 Uncharacterized protein
S. cerevisiae YIL100W 117 10 3 3.3 3 12 0.3 Uncharacterized protein
S. cerevisiae YKR047W 101 11 0 11.0 3 14 0.2 Uncharacterized protein
S. cerevisiae YLR204W 111 4 0 4.0 6 21 0.3
Mitochondrial mRNA-­‐
processing protein
COX24
D. melano. FBpp0304505 710 20 4 5.0 7 38 0.2 daughterless
D. melano. FBpp0302697 103 9 1 9.0 4 13 0.3 Uncharacterized protein
D. melano. FBpp0297202 119 8 2 4.0 1 9 0.1 Dmel_CG15219
D. melano. FBpp0071997 181 4 1 4.0 1 23 0.0 Uncharacterized protein
D. melano. FBpp0290488 110 4 0 4.0 3 20 0.2 Uncharacterized protein
D. melano. FBpp0099694 381 10 3 3.3 9 34 0.3
Activating transcription
factor-­‐2
D. melano. FBpp0305238 153 6 0 6.0 1 26 0.0 Dmel_CG17362
D. melano. FBpp0075507 161 8 0 8.0 1 26 0.0 Dmel_CG9040
D. melano. FBpp0075435 113 5 1 5.0 2 7 0.3 Uncharacterized protein
D. melano. FBpp0081955 514 11 2 5.5 8 36 0.2 Uncharacterized protein
D. melano. FBpp0083100 218 11 0 11.0 5 16 0.3 Dmel_CG7715
D. melano. FBpp0084113 653 26 6 4.3 31 110 0.3 Dmel_CG5808
D. melano. FBpp0084347 158 20 6 3.3 2 9 0.2 Dmel_CG14550
D. melano. FBpp0288515 755 24 6 4.0 8 37 0.2 kayak
D. melano. FBpp0070527 272 6 1 6.0 10 35 0.3 Dmel_CG14422
D. melano. FBpp0070947 318 10 2 5.0 4 39 0.1 Dmel_CG14440
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Table 3.1. continued 
Species Name length
N'
FWY
C'
FWY
FWY
ratio
N'
RK
C'
RK
RK
ratio Functional Annotation
H. sapiens ENSP00000302665 195 12 3 4.0 8 28 0.3
insulin-­‐like growth factor 1
(somatomedin C)
H. sapiens ENSP00000402118 190 12 1 12.0 7 22 0.3
proteasome (prosome,
macropain) subunit, alpha type, 4
H. sapiens ENSP00000419768 147 18 2 9.0 0 10 0.1 ATPase, class VI, type 11B
H. sapiens ENSP00000438313 218 4 1 4.0 1 16 0.1
WNK lysine deficient protein
kinase 1
H. sapiens ENSP00000439957 320 18 2 9.0 9 30 0.3
splicing factor, arginine/serine-­‐rich
8
H. sapiens ENSP00000411516 325 11 2 5.5 2 14 0.1
sterol regulatory element binding
transcription factor 1
H. sapiens ENSP00000461971 133 7 2 3.5 2 12 0.2
nuclear factor (erythroid-­‐derived
2)-­‐like 1
H. sapiens ENSP00000392000 166 5 0 5.0 3 22 0.1 GNAS complex locus
H. sapiens ENSP00000399644 677 26 8 3.3 14 53 0.3
RAB11 family interacting protein 3
(class II)
H. sapiens ENSP00000472176 182 12 3 4.0 6 19 0.3 mucolipin 1
H. sapiens ENSP00000397588 134 5 1 5.0 3 12 0.3 protein interacting with PRKCA 1
H. sapiens ENSP00000457401 166 7 1 7.0 0 4 0.3
TOX high mobility group box
family member 3
H. sapiens ENSP00000470027 253 16 5 3.2 4 13 0.3 mediator complex subunit 25
H. sapiens ENSP00000429628 173 8 2 4.0 4 18 0.2 zinc finger protein 419
H. sapiens ENSP00000395180 105 4 1 4.0 1 15 0.1
TCF3 (E2A) fusion partner (in
childhood Leukemia)
H. sapiens ENSP00000471612 134 7 1 7.0 3 11 0.3 transmembrane protein 59-­‐like
H. sapiens ENSP00000405308 106 7 1 7.0 1 4 0.3 claudin 15
H. sapiens ENSP00000361148 147 12 1 12.0 3 14 0.2
vascular endothelial growth factor
A
H. sapiens ENSP00000388105 101 4 1 4.0 2 10 0.2
family with sequence similarity
176, member A
H. sapiens ENSP00000378568 389 7 1 7.0 8 78 0.1
splicing factor, arginine/serine-­‐rich
11
H. sapiens ENSP00000358094 121 13 2 6.5 1 9 0.1
chromosome 1 open reading
frame 54
H. sapiens ENSP00000451040 170 8 2 4.0 5 21 0.2 placental growth factor
H. sapiens ENSP00000465552 237 10 2 5.0 1 25 0.0
FBJ murine osteosarcoma viral
oncogene homolog B
H. sapiens ENSP00000465317 158 5 1 5.0 2 9 0.2
mitochondrial rRNA
methyltransferase 1 homolog (S.
cerevisiae)
H. sapiens ENSP00000426127 105 7 2 3.5 1 13 0.1 zinc finger protein 331
H. sapiens ENSP00000469221 162 13 3 4.3 4 18 0.2
DnaJ (Hsp40) homolog, subfamily
B, member 1
H. sapiens ENSP00000358242 805 29 8 3.6 39 130 0.3
splicing factor, arginine/serine-­‐rich
18
H. sapiens ENSP00000462200 200 16 4 4.0 2 11 0.2
solute carrier family 39 (metal ion
transporter), member 11
H. sapiens ENSP00000473322 101 6 1 6.0 1 7 0.1 lysyl oxidase-­‐like 2
H. sapiens ENSP00000447828 107 6 1 6.0 1 4 0.3
PH domain and leucine zipper
containing 2
H. sapiens ENSP00000386288 117 7 0 7.0 2 10 0.2
signal transducer and activator of
transcription 4
H. sapiens ENSP00000454110 121 7 0 7.0 2 8 0.3 dual oxidase maturation factor 2
H. sapiens ENSP00000427040 128 6 0 6.0 2 11 0.2
DNA-­‐damage-­‐inducible transcript
4-­‐like
H. sapiens ENSP00000429229 197 15 2 7.5 5 17 0.3 ER lipid raft associated 2
141
Table 3.1. continued 
Species Name length
N'
FWY
C'
FWY
FWY
ratio
N'
RK
C'
RK
RK
ratio Functional Annotation
H. sapiens ENSP00000435422 282 16 4 4.0 5 27 0.2
Wolf-­‐Hirschhorn syndrome
candidate 1-­‐like 1
H. sapiens ENSP00000417243 125 5 0 5.0 3 15 0.2 integrin, beta 1
H. sapiens ENSP00000368116 145 9 1 9.0 4 22 0.2 coiled-­‐coil domain containing 3
H. sapiens ENSP00000470111 148 8 2 4.0 2 9 0.2 zinc finger protein 547
H. sapiens ENSP00000385379 150 10 3 3.3 5 17 0.3
nuclear receptor subfamily 4,
group A, member 2
H. sapiens ENSP00000334538 624 19 1 19.0 28 126 0.2
splicing factor, arginine/serine-­‐rich
12
H. sapiens ENSP00000416227 244 9 2 4.5 8 31 0.3 mediator complex subunit 19
H. sapiens ENSP00000356998 282 11 3 3.7 5 25 0.2 upstream transcription factor 1
H. sapiens ENSP00000432600 127 7 1 7.0 0 7 0.1
von Willebrand factor A domain
containing 5B1
H. sapiens ENSP00000455891 121 4 0 4.0 2 11 0.2
ring finger and SPRY domain
containing 1
H. sapiens ENSP00000371820 112 5 0 5.0 3 13 0.2
C1q and tumor necrosis factor
related protein 7
H. sapiens ENSP00000295400 160 6 1 6.0 2 10 0.2 transforming growth factor, alpha
H. sapiens ENSP00000469318 122 6 0 6.0 2 7 0.3 kallikrein-­‐related peptidase 2
H. sapiens ENSP00000476179 203 10 2 5.0 7 22 0.3
PX domain containing
serine/threonine kinase
H. sapiens ENSP00000447188 169 8 0 8.0 1 19 0.1
DNA-­‐damage-­‐inducible transcript
3
H. sapiens ENSP00000472057 148 4 1 4.0 6 21 0.3
regulator of chromosome
condensation 1
H. sapiens ENSP00000324775 156 7 2 3.5 4 25 0.2 transmembrane inner ear
H. sapiens ENSP00000329557 159 7 1 7.0 4 13 0.3 transmembrane protein 89
H. sapiens ENSP00000410814 219 19 4 4.8 8 31 0.3
nuclear pore complex interacting
protein
H. sapiens ENSP00000436315 138 6 1 6.0 3 14 0.2
RNA-­‐binding region (RNP1, RRM)
containing 3
H. sapiens ENSP00000427067 142 7 2 3.5 2 10 0.2
zinc finger, DHHC-­‐type containing
11
H. sapiens ENSP00000455285 125 11 3 3.7 2 8 0.3 methyltransferase like 9
H. sapiens ENSP00000466265 102 7 2 3.5 2 7 0.3 zinc finger protein 607
H. sapiens ENSP00000359566 103 4 1 4.0 2 9 0.2 hypothetical protein LOC286411
H. sapiens ENSP00000448481 116 5 1 5.0 0 13 0.1 proline rich 13
H. sapiens ENSP00000392933 107 4 0 4.0 3 14 0.2 HLA-­‐B associated transcript 4
H. sapiens ENSP00000392227 188 12 3 4.0 5 17 0.3 Uncharacterized protein
H. sapiens ENSP00000406761 107 4 0 4.0 3 14 0.2
G patch domain and ankyrin
repeats 1
H. sapiens ENSP00000414033 104 5 1 5.0 0 10 0.1 Uncharacterized protein
H. sapiens ENSP00000433093 109 7 2 3.5 3 13 0.2 zinc finger, BED-­‐type containing 5
H. sapiens ENSP00000475001 122 6 0 6.0 3 12 0.3 TLX1 neighbor
H. sapiens ENSP00000411450 108 6 1 6.0 2 9 0.2
eukaryotic translation initiation
factor 6
H. sapiens ENSP00000454033 114 4 0 4.0 3 12 0.3 Uncharacterized protein
H. sapiens ENSP00000463993 121 13 2 6.5 1 9 0.1 Uncharacterized protein
H. sapiens ENSP00000473947 105 4 1 4.0 1 15 0.1
TCF3 (E2A) fusion partner (in
childhood Leukemia)
H. sapiens ENSP00000475235 160 6 1 6.0 2 10 0.2
transforming growth factor,
alpha
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